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The vertebrate adaptive immune system provides a flexible and diverse set of molecules to neu-
tralize pathogens. Yet, viruses such as HIV can cause chronic infections by evolving as quickly as
the adaptive immune system, forming an evolutionary arms race. Here we introduce a mathemat-
ical framework to study the coevolutionary dynamics of antibodies with antigens within a host.
We focus on changes in the binding interactions between the antibody and antigen populations,
which result from the underlying stochastic evolution of genotype frequencies driven by mutation,
selection, and drift. We identify the critical viral and immune parameters that determine the distri-
bution of antibody-antigen binding affinities. We also identify definitive signatures of coevolution
that measure the reciprocal response between antibodies and viruses, and we introduce experimen-
tally measurable quantities that quantify the extent of adaptation during continual coevolution of
the two opposing populations. Using this analytical framework, we infer rates of viral and immune
adaptation based on time-shifted neutralization assays in two HIV-infected patients. Finally, we an-
alyze competition between clonal lineages of antibodies and characterize the fate of a given lineage
in terms of the state of the antibody and viral populations. In particular, we derive the conditions
that favor the emergence of broadly neutralizing antibodies, which may be useful in designing a
vaccine against HIV.
Introduction
It takes decades for humans to reproduce, but our
pathogens can reproduce in less than a day. How can we
coexist with pathogens whose potential to evolve is 104-
times faster than our own? In vertebrates, the answer lies
in their adaptive immune system, which uses recombina-
tion, mutation, and selection to evolve a response on the
same time-scale at which pathogens themselves evolve.
One of the central actors in the adaptive immune sys-
tem are B-cells, which recognize pathogens using highly
diverse membrane-bound receptors. Naive B-cells are
created by processes which generate extensive genetic di-
versity in their receptors via recombination, insertions
and deletions, and hypermutations [1] which can poten-
tially produce ∼ 1018 variants in a human repertoire [2].
This estimate of potential lymphocyte diversity outnum-
bers the total population size of B-cells in humans, i.e.,
∼ 1010 [3, 4]. During an infection, B-cells aggregate to
form germinal centers, where they hypermutate at a rate
of about ∼ 10−3 per base pair per cell division over a
region of 1-2 kilo base pairs [5]. The B-cell hypermu-
tation rate is approximately 4 − 5 orders of magnitude
larger than an average germline mutation rate per cell
division in humans [6]. Mutated B-cells compete for sur-
vival and proliferation signals from helper T-cells, based
on the B-cell receptor’s binding to antigens. This form
of natural selection is known as affinity maturation, and
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it can increase binding affinities up to 10-100 fold [7–9],
see Fig. 1A. B-cells with high binding affinity may leave
germinal centers to become antibody secreting plasma
cells, or dormant memory cells that can be reactivated
quickly upon future infections [1]. Secreted antibodies,
which are the soluble form of B-cell receptors, can bind
directly to pathogens to mark them for neutralization by
other parts of the immune system. Plasma B-cells may
recirculate to other germinal centers and undergo further
hypermutation [8].
Some viruses, such as seasonal influenza viruses, evolve
quickly at the population level, but the adaptive immune
system can nonetheless remove them from any given host
within a week or two. By contrast, chronic infections can
last for decades within an individual, either by pathogen
dormancy or by pathogens avoiding neutralization by
evolving as rapidly as B-cell populations. HIV mutation
rates, for example, can be as high as 0.1− 0.2 per gener-
ation per genome [10]. Neutralizing assays and phyloge-
netic analyses suggest an evolutionary arms race between
B-cells and HIV populations during infection in a single
patient [11–15]. Viruses such as HIV have evolved to
keep the sensitive regions of their structure inaccessible
by the immune system e.g., through glycan restriction or
immuno-dominant variable loops [16, 17]. As a result,
the majority of selected antibodies bind to the most eas-
ily accessible regions of the virus, where viruses can tol-
erate mutations and thereby escape immune challenge.
Nonetheless, a remarkably large proportion of HIV pa-
tients (∼ 20%) eventually produce antibodies that neu-
tralize a broad panel of virions [18, 19] by attacking struc-
turally conserved regions, such as the CD4 binding site
of HIV env protein [14, 20–23]. These broadly neutraliz-
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2ing antibodies (BnAbs), can even neutralize HIV viruses
from other clades, suggesting it may be possible to de-
sign an effective HIV vaccine if we can understand the
conditions under which BnAbs arise [14, 20, 23–27].
Recent studies have focused on mechanistic modeling
of germinal centers in response to one or several antigens
[7, 28], and elicitation of BnAbs [27, 29]. However, these
studies did not model the coevolution of the virus and
B-cell repertoire, which is important to understand how
BnAbs arise in vivo. Modeling of such coevolution is dif-
ficult because the mechanistic details of germinal center
activity are largely unknown [15, 30], and the multitude
of parameters make it difficult to identify generalizable
aspects of a model. While evidence of viral escape mu-
tations and B-cell adaptation has been observed exper-
imentally [11–14] and modeled mechanistically [27, 29],
it is not clear what are the generic features and relevant
parameters in an evolutionary arms race that permit the
development, or, especially, the early development of Bn-
Abs. Phenomenological models ignore many details of
affinity maturation and heterogeneity in the structure of
germinal centers and yet produce useful qualitative pre-
dictions [15, 30, 31]. Past models typically described only
a few viral types [27, 28], and did not account for the vast
genetic diversity and turnover seen in infecting popula-
tions. A recent study by Luo & Perelson [30] described
diverse viral and antibody populations, relying primarily
on numerical simulations.
In this paper, we take a phenomenological approach
to model the within-host coevolution of diverse pop-
ulations of B-cells and chronic viruses. We focus on
the chronic infection phase, where the immune response
is dominated by HIV-specific antibody-mediated mech-
anisms, which follow the strong response by the cyto-
toxic T-lymphocytes (i.e., CD8+ killers T-cells), around
50 days after infection [32]. During the chronic phase,
population sizes of viruses and lymphocytes are relatively
constant but their genetic compositions undergo rapid
turnover [33]. We characterize the interacting sites of
B-cell receptors and viruses as mutable binary strings,
with binding affinity, and therefore selection, defined by
matching bits. We keep track of both variable regions
in the viral genome and conserved regions, asking specif-
ically when B-cell receptors will evolve to bind to the
conserved region, i.e., to develop broad neutralization ca-
pacity. The main simplification that makes our analysis
tractable is that we focus on the evolution of a shared in-
teraction phenotype, namely the distribution of binding
affinities between viral and receptor populations. Specif-
ically, we model the effects of mutations, selection and
reproductive stochasticity on the distribution of binding
affinities between the two populations. Projecting from
the high-dimensional space of genotypes to lower dimen-
sion of binding phenotypes allows for a predictive and
analytical description of the coevolutionary process [34],
whilst retaining the salient information about the quan-
tities of greatest biological and therapeutic interest.
Using this modeling approach we show that the
evolution of the binding affinity does not depend on
details of any single-locus contribution, but is an emerg-
ing property of all constitutive loci. Even though the
coevolution of antibodies and viruses is perpetually out
of equilibrium, we develop a framework to quantify the
amount of adaptation in each of the two populations
by defining fitness and transfer flux, which partition
changes in mean fitness. We discuss how to measure the
fitness and transfer flux from time-shifted experiments,
where viruses are competed against past and future an-
tibodies, and we show how such measurements provide a
signature of coevolution. We use these analytical results
to interpret empirical measurements of time-shifted neu-
tralization assays from two HIV-infected patients [11],
and we infer two qualitatively different regimes of
viral-antibody coevolution. We discuss the consequences
of competition between clonal B-cell lineages within
and between germinal centers. In particular, we derive
analytic expressions for the fixation probability of a
newly arisen, broadly neutralizing antibody lineage. We
find that BnAbs have an elevated chance of fixation
in the presence of a diverse viral population, whereas
specific neutralizing antibody lineages do not. We
discuss the implications of these results for the design of
preventive vaccines that elicit BnAbs against HIV.
Model
Interaction between antibodies and viruses
B-cell receptors undergo mutation and selection in ger-
minal centers, whereas viruses are primarily affected by
the receptors secreted into the blood, known as antibod-
ies. Our model does not distinguish between antibodies
and B-cells, so we will use the terms interchangeably. To
represent genetically diverse populations we define geno-
types for antibodies and viruses as binary sequences of
±1, where mutations change the sign of individual loci.
Mutations in some regions of a viral genome are highly
deleterious, e.g. at sites that allow the virus to bind tar-
get cell receptors, including CD4-binding sites for HIV.
To capture this property we explicitly model a conserved
region of the viral genome that does not tolerate muta-
tions, so that its bits are always set to +1. We let viruses
have variable bits at positions i = 1 . . . `, and conserved
bits at positions i = `+1, . . . , `+ ˆ`; while antibodies have
variable bits at positions i = 1 . . . `+ ˆ`; see Fig. 1B.
Naive B-cells generate diversity by gene rearrange-
ments (VDJ recombination), which differentiates their
ability to bind to different epitopes of the virus; and then
B-cells diversify further by somatic hypermutation and
selection during affinity maturation. We call the set of
3FIG. 1: coevolution of antibodies and viruses. (A)
Schematic of affinity maturation in a germinal center. A
naive, germline B-cell receptor (black) with marginal binding
affinity for the circulating antigen (red pentagon) enters the
process of affinity maturation in a germinal center. Hypermu-
tations produce a diverse set of B-cell receptors (colors), the
majority of which do not increase the neutralization efficacy
of B-cells, except for some beneficial mutations that increase
binding affinity (dark blue and green) to the presented anti-
gen. The selected B-cells may enter the blood and secrete
antibodies, or enter further rounds of hypermutations to en-
hance their neutralization ability. Antigens mutate and are
selected (yellow pentagon) based on their ability to escape
the current immune challenge. (B) We model the interaction
between the genotype of a B-cell receptor and its secreted an-
tibody (blue) with a viral genotype (red) in both variable and
conserved regions of the viral genome. The black and white
circles indicate the state of the interacting loci with values ±1.
Loci in the conserved region of the virus are fixed at +1. The
length of the arrows indicate the contribution of each locus to
the binding affinity, κi, which is a measure of the accessibility
of an antibody lineage to viral epitopes. The blue arrows in-
dicate the interactions that increase binding affinity (i.e., loci
with same signs in antibody and viral genotype), whereas red
arrows indicate interaction that decrease the affinity (i.e., loci
with opposite signs in antibody and viral genotype.)
B-cells that originate from a common germline sequence
a clonal lineage. A lineage with access to conserved re-
gions of the virus can effectively neutralize more viral
genotypes, since no escape mutation can counteract this
kind of neutralization.
The binding affinity between antibody and virus deter-
mines the likelihood of a given antigen neutralization by
an antibody, and therefore it is the key molecular pheno-
type that determines selection on both immune and viral
populations. We model the binding affinity as a weighted
dot product over all loci, which for antibody Aα chosen
from the genotype space α ∈ 1 . . . 2`+ˆ` and virus V γ with
γ ∈ 1 . . . 2` has binding affinity
EC
tot
(Aα, V γ) =
∑`
i=1
κCi A
α
i V
γ
i︸ ︷︷ ︸
variable viral region
+
`+ˆ`∑
i=`+1
κˆCi A
α
i︸ ︷︷ ︸
conserved viral region
≡ ECαγ + EˆCα (1)
where, Aαi = ±1 denotes the ith locus of the α antibody
genotype, and V γi the i
th locus of the γ viral genotype.
Matching bits at interacting positions enhance binding
affinity between an antibody and a virus; see Fig. 1B.
Similar models have been used to describe B-cell matu-
ration in germinal centers [27], and T-cell selection based
on the capability to bind external antigens and avoid self
proteins [35, 36]. The conserved region of the virus with
Vi = 1 is located at positions i = ` + 1, . . . , ` + ˆ` for all
viral sequences. Consequently, the total binding affinity
is decomposed into the interaction with the variable re-
gion of the virus, ECαγ and with the conserved region of
the virus, EˆCα. We call the lineage-specific binding con-
stants {κCi ≥ 0} and {κˆCi ≥ 0} the accessibilities, because
they characterize the intrinsic sensitivity of an antibody
lineage to individual sites in viral epitopes. We begin by
analyzing the evolution of a single antibody lineage, and
suppress the C notation for brevity. Coevolution with
multiple antibody lineages is discussed in a later section.
Both antibody and viral populations are highly
polymorphic, and therefore contain many unique geno-
types. While the binding affinity between a virus V γ
and an antibody Aα is constant, given by eq. (1),
the frequencies of the antibody and viral genotypes,
xα and yγ , and all quantities derived from them,
change over time as the two populations coevolve.
To characterize the distribution of binding affinities
we define the genotype-specific binding affinities in
each population, which are marginalized quantities
over the opposing population: Eα · =
∑
γ Eαγy
γ for
the antibody Aα, and E. γ =
∑
αEαγx
α for the virus
V γ . We will describe the time evolution of the joint
distribution of Eα ·, Eˆα, and E· γ , by considering three of
its moments: (i) the mean binding affinity, which is the
same for both populations E = ∑αEα ·xα = ∑γ E· γyγ ,
(ii) the diversity of binding affinity in the antibodies,
MA,2 =
∑
α (Eα · − E)2 xα and (iii) the diversity of
binding affinities in the viruses, MV,2 =
∑
γ (E· γ − E)2 yγ .
Analogous statistics of binding affinities can be defined
for the conserved region of the virus, which we denote
by Eˆ for the mean interaction, and MˆA,2 for the diversity
across antibodies. The diversity of viral interactions
in the conserved region must always equal zero, MˆV,2 = 0.
4Coevolution of an antibody lineage and viruses
We first characterize the affinity maturation process of
a single clonal antibody lineage coevolving with a viral
population, which includes hypermutation, selection,
and stochasticity due to population size in germinal
centers, i.e., genetic drift.
Genetic drift and evolutionary time-scales. Stochas-
ticity in reproductive success, known as genetic drift, is
an important factor that depends on population size, and
therefore we model genetic drift by keeping populations
at finite size Na for antibodies, and Nv for viruses. Al-
though the population of B-cells can reach large numbers
within an individual host, significant bottlenecks occur
in germinal centers, where there may be on the order of
∼ 103 − 104 B-cells [7]. For HIV, estimates for intra-
patient viral divergence suggests an effective population
size of about ∼ 102−103, which is much smaller than the
number of infected cells within a patient ∼ 107−109 [37].
Fluctuations by genetic drift define an important
time-scale in the evolution of a polymorphic population:
the neutral coalescence time is the characteristic time
that two randomly chosen neutral alleles in the popu-
lation coalesce to their most recent common ancestor,
and is equal to N generations. Neutral coalescence
time is estimated by phylogenetic analysis, and is often
interpreted as an effective population size, which may be
different from the census population size. Coalescence
time can be mapped onto real units of time (e.g.,
days) if sequences are collected with sufficient time
resolution. Without loss of generality, we assume that
generation times in antibodies and viruses are equal,
but we distinguish between the neutral coalescence time
of antibodies and viruses by using distinct values for
their population sizes, i.e., Na in antibodies and Nv in
viruses.
Mutations. In the bi-allelic model outlined in Fig. 1B,
a mutation changes the sign of an antibody site,
i.e., Aαi → −Aαi , affecting binding affinity in proportion to
the lineage’s intrinsic accessibility at that site, κi. There-
fore, a mutation in an antibody at position i changes Eα .
by δiEα . = −2κiAαi
∑
γ V
γ
i y
γ . Likewise, a mutation at po-
sition j of a virus V γj → −V γj affects binding affinity in
proportion to κj . We assume constant mutation rates in
the variable regions of the viruses and antibodies: µv and
µa per site per generation.
Empirical estimates of per-generation mutation rates
for viruses µv or hypermutation rates of BCR sequences
µa are extremely imprecise, and so we rescale mutation
rates by neutral coalescence times. To do this, we
consider measurements of standing neutral sequence
diversity, estimated from genetic variation in, e.g.,
four-fold synonymous sites of protein sequences at each
position. Neutral sequence diversity for the antibody
variable region, which spans a couple of hundred base
pairs, is about θa = Naµa = 0.05 − 0.1 [2]. Nucleotide
diversity of HIV increases over time within a patient,
and ranges between θv = Nvµv = 10
−3 − 10−2 in the
env protein of HIV-1 patients, with a length of about
a thousand base pairs [38]. Interestingly, the total
diversity of the variable region in BCRs is comparable to
the diversity of its main target, the env protein, in HIV.
Both populations have on the order of 1-10 mutations
per genotype per generation, which we use as a guideline
for parameterizing simulations of our model.
Selection. Frequencies of genotypes change according
to their relative growth rate, or fitness. The change
in the frequency of antibody Aα with fitness fAα is
∆xα = (fAα − FA)xα per generation, where we define
(malthusian) fitness as proportional to the growth rate,
and FA =
∑
α fAαx
α denotes the mean fitness of the anti-
body population (see Section A of the Appendix). Like-
wise, the change in frequency of virus V γ due to selection
per generation is, ∆ yγ = (fV γ −FV )yγ , where FV denotes
the mean fitness in the viral population.
During affinity maturation in a germinal center, a B-
cell’s growth rate depends on its ability to bind to the
limited amounts of antigen, and to solicit survival sig-
nals from helper T-cells [8]. At the same time, viruses are
neutralized by antibodies that have high binding affinity.
The simplest functional form that approximates this pro-
cess, and for which we can provide analytical insight, is
linear with respect to the binding affinity,
fAα = Sa(Eα · + Eˆα) (2)
fV γ = −Sv(E· γ + Eˆ·) (3)
for antibody Aα and virus V γ . The selection coefficient
Sa > 0 quantifies the strength of selection on the binding
affinity of antibodies. The value of Sa may decrease in
late stages of a long-term HIV infection, as the host’s
T-cell count decays [31], but we do not model this be-
havior. The viral selection coefficient Sv > 0 represents
immune pressure impeding the growth of the virus. The
contribution of the conserved region to the fitness of the
virus is independent of the viral genotype in eq. (3), and
it does not affect the relative growth rates of the viral
strains.
The number of sites and the magnitude of their acces-
sibilities affect the overall strength of selection on bind-
ing affinity. Therefore, it is useful to absorb the intrin-
sic effects of the phenotype magnitude into the selection
strength, and use rescaled values that are comparable
across lineages of antibodies, and across experiments. We
therefore rescale quantities related to the binding affin-
ity by the total scale of the phenotypes E20 =
∑
i κ
2
i and
Eˆ20 =
∑
i κˆ
2
i , such that Eαγ → Eαγ/E0 and Eˆαγ → Eˆαγ/Eˆ0,
resulting in rescaled mean binding affinities ε and εˆ, and
5diversities mA,2, mˆA,2 and mV,2 in variable and conserved
regions of both populations. Accordingly, we define
rescaled selection coefficients sa = NaSaE0, sˆa = NaSaEˆ0,
sv = NvSvE0 and sˆv = NvSvEˆ0, which describe the total
strength of selection on binding affinity; see Section B.1
of the Appendix for details.
Many aspects of affinity maturation are not well
known, and so it is worth considering other forms of
selection. In Section B.5 of the Appendix we describe
fitness as a non-linear function of the binding affinity.
In particular, we consider fitness that depends on the
antibody activation probability, which is a sigmoid
function of the strongest binding affinity among a finite
number of interactions with antigens. The linear fitness
function in eq. (2) is a limiting case of this more general
fitness model. While most of our analytical results are
based on the assumption of linear fitness function, we
also discuss how to quantify adaptation for arbitrary
fitness models, and we numerically study the effect of
nonlinearity on the rate of antibody adaptation during
affinity maturation.
Results
Evolution of the mean binding affinity
We focus initially on understanding the (rescaled)
mean binding affinity ε, εˆ between a clonal antibody lin-
eage and the viral population, since this is a proxy for
the overall neutralization ability that is commonly mon-
itored during an infection. Combining genetic drift with
mutation and selection, and assuming a continuous-time
and continuous-frequency process, results in a stochastic
dynamical equation for the evolution of rescaled mean
binding affinity in the variable region,
d
dτ
ε =− 2 [θa + θv(NA/Nv)] ε+ samA,2 − svmV,2
+
√
mA,2 +
Na
Nv
mV,2 χε (4)
and in the conserved region,
d
dτ
εˆ = −2θaεˆ+ samˆA,2 +
√
mˆA,2χεˆ (5)
where χε and χεˆ are standard Gaussian noise terms,
and time τ is measured in units of the antibody coa-
lescence time Na. Our analysis neglects the correlation
between the variable and the conserved regions of the
virus, which is due to physical linkage of the segments.
In Section B.4 of the Appendix we show that a difference
in evolutionary time-scales between these regions reduces
the magnitude of this correlation.
FIG. 2: Effect of selection on immune-virus binding
affinity. The stationary mean binding affinity, rescaled by
antibody binding diversity (E/√MA,2/4θa), on the y-axis,
is well approximated by the scaled selection difference be-
tween antibody and viral populations, ∆sav, as predicted by
our analysis (eq. (6)). Points show results of Wright-Fisher
simulations, and the solid line has slope 1. Note that the
mean binding affinity is insensitive to the details of heteroge-
neous binding accessibilities, κi, associated with an antibody
lineage. Accessibilities κi are drawn from several different Γ-
distributions, shown in legend. Small deviations from the pre-
dicted mean binding are caused by higher moments of binding
affinities, which can also be understood analytically (Fig. S1).
Simulation parameters are detailed in the Appendix.
As eqs. (4, 5) reflect, mutations drive the mean affinity
towards the neutral value, zero, whereas selection pushes
it towards positive or negative values. The efficacy of
selection on binding affinity is proportional to the bind-
ing diversity mA,2, mV,2 in each of the populations. If a
population harbors a large diversity of binding affinities
then it has more potential for adaptation from the fa-
vorable tail of the distribution, which contains the most
fit individuals in each generation [39, 40]. It follows that
selection on viruses does not affect the evolution of their
conserved region, where the viral diversity of binding is
always zero, mˆV,2 = 0. In Section B.3 of the Appendix
and Fig. S2 we study the evolution of the higher central
moments in detail.
The dynamics in eqs. (4,5) simplify in the regime where
selection on individual loci is weak (NSκ < 1), but the ad-
ditive effects of selection on the total binding affinity are
substantial (1 > s  θ−1). This evolutionary regime is,
in particular, relevant for HIV escape from the humoral
neutralizing antibody response [38], that follows the ini-
tial strong response to cytotoxic T-lymphocytes [41]. In
this parameter regime, the binding diversities are fast
variables compared to the mean affinity, and can be ap-
proximated by their stationary ensemble-averaged values
(Fig. S3), which depend only weakly on the strength of
selection even for substantial selection s ∼ 1: 〈mA,2〉 ' 4θa
and 〈mV,2〉 ' 4θv. Higher-order corrections (Section B.3
of the Appendix and Fig. S2) show that strong selection
6reduces binding diversity. The ensemble-averaged mean
binding affinities relax exponentially towards their sta-
tionary values,
〈ε〉 ' 2(saθa − svθv(Na/Nv))
θa + θv(Na/Nv)
≡ 2 ∆sav (6)
〈εˆ〉 ' 2 sˆa (7)
where ∆sav is an effective selection coefficient for bind-
ing affinity in the variable region, combining the effect of
selection from both populations and accounting for their
distinct genetic diversities. The stationary mean binding
affinity quantifies the balance of mutation and selection
acting on both populations. A strong selection differ-
ence between two populations ∆sav  1 results in selec-
tive sweeps for genotypes with extreme values of binding
affinity in each population, and hence, reduces the bind-
ing diversity. We validated our analytical solution for
stationary mean binding, with corrections due to selec-
tion on binding diversity (Section B.3 of the Appendix),
by comparison with full, genotype-based Wright-Fisher
simulations across a broad range of selection strengths
(Figs. S1 and S2).
The weak dependence of binding diversity on selection
allows for an experimental estimation of the stationary
rescaled mean binding affinity, using measurements of the
binding affinity distribution and neutral sequence diver-
sities. The rescaled binding affinity can be approximated
as: ε ≈ 〈E〉/√〈MA,2〉/4θa and εˆ ≈ 〈Eˆ〉/√〈MˆA,2〉/4θa.
Fig. 2 demonstrates the utility of this approximation,
and it shows that heterogeneous binding accessibilities,
κi, drawn from several different distributions, do not
affect stationary mean binding. Only the total magni-
tude of the accessibilities is relevant, as it determines
the effect of selection on the whole phenotype. Although
we have formulated a high-dimensional stochastic model
of antibody-antigen coevolution in polymorphic popula-
tions, we can nonetheless understand the long-term bind-
ing affinities, which are commonly measured in patients,
in terms of only a few key parameters.
In Section B.5 of the Appendix we numerically study
the non-linear fitness landscapes described in the Model
section, and their effect on the stationary mean binding
and rate of adaptation (Fig. S4). While the results differ
quantitatively, we can qualitatively understand how the
stationary mean binding affinity depends on the form of
non-linearity.
Fitness and transfer flux
The antagonistic coevolution of antibodies and viruses
is a non-equilibrium process, with each population con-
stantly adapting to a dynamic environment, namely, the
FIG. 3: Fitness and transfer flux in antibody-viral co-
evolution. The schematic diagram shows adaptation of anti-
body (blue diamond) and viral (red diamond) populations on
their respective fitness landscapes, which depend on the com-
mon binding phenotype shown on the x-axis (i.e., the mean
binding affinity). During one step of antibody adaptation
(left), mean binding affinity increases (horizontal blue arrow)
to enhance the fitness of the antibody population, with a rate
equal to the antibody fitness flux φA (upward blue arrow).
In the regime of strong selection, the fitness flux is propor-
tional to the variance of fitness in the population; see eq. (8).
Adaptation of antibodies reduces the mean fitness in the vi-
ral population, with a rate proportional to the transfer flux
from antibodies to viruses TA→V (downward red/blue arrow).
On the other hand, viral adaptation (right) reduces the bind-
ing affinity and affects the fitness of both populations, with
rates proportional to the viral fitness flux φV (upward red
arrow) and the transfer flux from viruses to antibodies TV→A
(downward blue/red arrow); see eq. (9). Cumulative fitness
flux (the sum of upward arrows) and cumulate transfer flux
(the sum of downward arrows) over an evolutionary period
quantify the amount of adaptation and interaction in the two
antagonistic populations.
state of the opposing population. As a result, any time-
independent quantity, such as the stationary mean bind-
ing affinity studied above, is itself not informative for
the extent of coevolution that is occurring. For example,
a stationary mean binding affinity of zero (equivalently
∆sav = 0 in eq. (6)) can indicate either neutral evolu-
tion or rapid coevolution induced by equally strong se-
lection in antibody and viral populations. To quantify
the amount of adaptation and extent of interaction in
two coevolving populations we will partition the change
in mean fitness of each population into two components.
We measure adaptation by the fitness flux [42–44], which
generically quantifies adaptation of a population in re-
sponse to a changing environment (in this case the op-
posing population); see schematic Fig. 3. For our model,
the fitness flux of the antibody population quantifies the
effect of changing genotype frequencies on mean fitness,
and is defined as φA(t) =
∑
α ∂xαFA(t) dx
α(t)/dt, where FA
denotes the mean fitness of antibodies, and the derivative
dxα(t)/dt measures the change in frequency of the anti-
body Aα. The forces of mutation, drift, and selection all
contribute to fitness flux, however the portion of fitness
7flux due to selection equals the population variance of fit-
ness, in accordance with Fisher’s theorem [39]. The sec-
ond quantity we study, which we term the transfer flux,
measures the amount of interaction between the two pop-
ulations by quantifying the change in mean fitness due
to the response of the opposing population (schematic
Fig. 3). The transfer flux from viruses to antibodies is
defined as TV→A(t) = ∑γ ∂yγFA(t) dyγ(t)/dt. Analogous
measures of adaptation and interaction can be defined
for the viral population (see Section C of the Appendix).
The fitness flux and transfer flux represent rates of
adaptation and interaction, and they are typically time
dependent, except in the stationary state. The to-
tal amount of adaptation and interaction during non-
stationary evolution, where the fluxes change over time,
can be measured by the cumulative fluxes over a pe-
riod of time: ΦA(τa) = Na
∫ t
t′=0 φA(t
′) dt′ and TV→A(τa) =
Na
∫ t
t′=0 TV→A(t′) dt′, where time τa = t/Na is measured
in units of neutral coalescence time of antibodies Na. In
the stationary state, the ensemble-averaged cumulative
fluxes grow linearly with time. For coevolution on the
fitness landscapes given by equations (2,3), the ensemble-
averaged, stationary cumulative fitness flux and transfer
flux in antibodies are
〈ΦA(τa)〉 =
[− 2θasa〈ε〉+ s2a〈mA,2〉]τa (8)
〈TV→A(τa)〉 =
[− 2θvsa〈ε〉 − sasv〈mV,2〉](Na/Nv)τa
(9)
Note that the factor (Na/Nv)τa in eq. (9), which is a
rescaling of time in units of viral neutral coalescence time
τv = t/Nv, emphasizes the distinction between the evolu-
tionary time scales of antibodies and viruses. The first
terms on the right hand side of eqs. (8, 9) represent the
fitness changes due to mutation, the second terms are due
to selection, and the effects of genetic drift are zero in the
ensemble average for our linear fitness landscape. No-
tably, the flux due to the conserved region of the virus is
zero in stationarity, as is the case for evolution in a static
fitness landscape (i.e., under equilibrium conditions). In
the stationary state, the cumulative fitness and transfer
fluxes sum up to zero, 〈ΦA(τa)〉+ 〈TV→A(τa)〉 = 0.
Fitness flux and transfer flux are generic quantities
that are independent of the details of our model, and
so they provide a natural way to compare the rate of
adaptation in different evolutionary models or in different
experiments. In the regime of strong selection sa, sv & 1,
non-linearity of the fitness function results in a more nar-
row distribution of fitness values in the antibody popu-
lation, and hence, reduces the rate of adaptation and
fitness flux; see Fig. S4. In the following section we show
how to use fitness and transfer flux to detect signatures
of significant antibody-antigen coevolution.
Signature of coevolution and inferences from
time-shifted experiments
Measuring interactions between antibodies and viruses
isolated from different times provides a powerful way to
identify coevolution. These “time-shifted” neutralization
measurements in HIV patients have shown that viruses
are more resistant to past antibodies, from which they
have been selected to escape, and more susceptible to
antibodies from the future, due to selection and affinity
maturation of B-cells [11–13].
We can predict the form of time-shifted binding as-
says under our model; see Section D of the Appendix
for details. The rescaled time-shifted binding affinity be-
tween viruses at time t and antibodies at time t + τ is
given by ετ (t) =
∑
α,γ Eαγy
γ(t)xα(t + τ)/E0 and εˆτ (t) =∑
α Eˆαx
α(t+ τ)/Eˆ0 for the variable and the conserved re-
gion, respectively. The corresponding viral mean fitness
at time t against the antibody population at time t + τ
is NvFV ;τ (t) = −sv(ετ (t) + εˆτ (t)). The slope of the time-
shifted viral fitness at the time where the two populations
co-occur (i.e., τ = 0), approaching from negative τ , i.e.,
from the past, measures the amount of adaptation of the
viral population in response to the state of the antibody
population, and it is precisely equal to the fitness flux
of viruses: ∂τFV ;τ (t − τ)|τ=0− = φV (t). The slope ap-
proaching from positive time-shifts, i.e., from the future,
measures the change in the mean fitness of the viral pop-
ulation due to adaptation of the antibody population,
and it is precisely equal to the transfer flux from anti-
bodies to viruses ∂τFV ;τ (t)|τ=0+ = TA→V (t). Similarly,
we can define time-shifted fitness with antibodies as the
focal population; see Section D of the Appendix. In sta-
tionarity, the sum of fitness flux and transfer flux is zero
on average, and so the slopes from either side of τ = 0 are
equal, as in Fig. 4 and Fig. S5. Note that these relation-
ships between time-shifted fitness and the flux variables
hold in general, beyond the specific case of a linear fit-
ness landscape. In a non-stationary state, the fitness flux
and transfer flux are not balanced, and so 〈FV ;τ (t)〉 has
a discontinuous derivative at τ = 0 (Fig. S6). There-
fore, observation of such a discontinuity provides a way
to identify stationarity versus transient dynamics, given
sufficient replicated experiments.
Whether in stationarity or not, the signature of out-of-
equilibrium evolution is a positive fitness flux and neg-
ative transfer flux. For time-shifted fitness, this means
that for short time shifts, where dynamics are dominated
by selection, viruses have a higher fitness against antibod-
ies from the past, and have lower fitness against antibod-
ies from the future. This is true even when one popula-
tion is evolving neutrally and the other has substantial
selection, as shown in Fig. 4A. For long time shifts, the
sequences are randomized by mutations and the fitness
decays exponentially to the neutral value. When selec-
tion and mutation are substantial on both sides the time-
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FIG. 4: Time-shifted binding assays between antigens and antibodies provide a definitive signature of viral-
immune coevolution. Viruses perform best against antibodies from the past and perform worst against antibodies from
the future due to the adaptation of antibodies. (A) Stationary rescaled binding affinity between viruses from time t and
antibodies from time t + τ , averaged over all t: ετ = 〈∑α,γ Eαγyγ(t)xα(t + τ)〉t/E0, and (B) time-shifted mean fitness of
viruses NvFV ;τ = −svετ , are shown for three regimes of coevolutionary dynamics: strong adaptation of both populations
s2aθa ∼ s2vθv, with sa = sv = 2 (blue), stronger adaptation of viruses s2vθv  s2aθa with sv = 2, sa = 0 (red), and stronger
adaptation of antibodies s2aθa  s2vθv with sv = 0, sa = 2 (green). Wright-Fisher simulations (solid lines) are compared to
the analytical predictions from eqs. (S102, S103) in each regime (dashed lines). The “S”-shape curve in the blue regime is
a signature of two antagonistically coevolving populations svθv ∼ saθa. For large time-shifts, binding relaxes to its neutral
value, zero, as mutations randomize genotypes. In the absence of selection in one population, the time-shifted binding affinity
reflects adaptation of one population against stochastic variation in the other due to mutation and genetic drift. The slope
of time-shifted fitness at lag τ = 0 is the viral population’s fitness flux (slope towards the past) and the transfer flux from
the opposing population (slope towards the future), which are equal to each other in the stationary state. The slope of the
dotted lines indicate the predicted fitness flux and transfer flux (eqs. (8, 9). Time-shifted fitness shown here does not include
binding to the conserved region since that value is constant for all time-shifts in stationarity (see Fig. S6 for non-stationary
state). Simulation parameters are given in the Appendix. (C) Empirical time-shifted fitness measurements of HIV based on a
neutralization titer (IC50) [11], averaged over all time points with equal time-shift τ . Circles show averaged fitness ± 1 standard
error, and crosses show fitness at time-shifts with only a single data point. Solid lines show analytical fits of our model to the
data (see Section F of Appendix). In patient TN-1, viruses and antibodies experience a comparable adaptive pressure, with a
similar time-shift pattern to the blue “S-curve” in panel (B). In patient TN-3, however, adaptation in viruses is much stronger
than in antibodies, resulting in an imbalanced shape of the time-shifted fitness curve, similar to the red curve in panel (B).
shifted fitness curve has a characteristic “S” shape – a sig-
nature of coevolution, whose inflected form can be under-
stood in terms of the fitness and transfer fluxes. In Sec-
tion D of the Appendix we analytically derive the func-
tional form of the time-shifted binding affinity and fitness
dependent on the evolutionary parameters. Fig. 4A,B
and Fig. S5 show good agreement between Wright-Fisher
simulations and our analytical predictions in eqs. (S102,
S103) for the stationary time-shifted binding affinity and
viral fitness.
We can use our analytical results to interpret empir-
ical measurements of time-shifted viral neutralization
by a patient’s circulating antibodies. We analyzed
data from Richman et al. [11] on two HIV-infected
patients. We approximated the fitness of the virus
against a sampled serum (antibodies) as the logarithm
of the neutralization titer FV ' − log titer; here titer
is the reciprocal of antibody dilution where inhibition
reaches 50% (IC50) [45]. A signature of coevolution can
sometimes be obscured when the fitnesses of antibodies
and viruses also depend on time-dependent intrinsic and
environmental factors, such as drug treatments [45].
Therefore, we used fitness of a neutralization-sensitive
virus (NL43) as a control measurement to account for
the increasing antibody response during infection, shown
in Fig. S7. The relative time-shifted viral fitness in
Fig. 4C for the two HIV patients (TN-1 and TN-3),
match well with the fits of our analytical equations (see
Section F of the Appendix). The inferred parameter
values indicate two distinct regimes of coevolutionary
dynamics in the two patients. In patient TN-1, viruses
and antibodies experience a comparable adaptive pres-
sure, as indicated by the “S-curve” in Fig. 4C (blue
line), whereas in patient TN-3, adaptation in viruses
is much stronger than in antibodies, resulting in an
imbalanced shape of the time-shifted fitness curve in
Fig. 4C (red line). We describe the inference procedure
and report all inferred parameters in Section F of the
Appendix. The resolution of the data [11] allows only for
a qualitative interpretation of coevolutionary regimes.
A more quantitative analysis can be achieved through
longer monitoring of a patient, detailed information on
the inhibition of viral replication at various levels of
antibody dilution, and directed neutralization assays
against HIV-specific antibody lineages.
9Competition between multiple antibody lineages
B-cells in the adaptive immune system are associated
with clonal lineages that originate from distinct ancestral
naive cells, generated by germline rearrangements (VDJ
recombination) and junctional diversification [1]. Mul-
tiple lineages may be stimulated within a germinal cen-
ter, and also circulate to other germinal centers [8]. Lin-
eages compete for activation agents (e.g., helper T-cells)
and interaction with a finite number of presented anti-
gens [8]. We extend our theoretical framework to study
how multiple lineages compete with each other and coe-
volve with viruses. This generalization allows us to show
that lineages with higher overall binding ability, higher
fitness flux, and lower (absolute) transfer flux have a bet-
ter chance of surviving. In particular, we show that an
antibody repertoire fighting against a highly diversified
viral population, e.g., during late stages of HIV infec-
tion, favors elicitation of broadly neutralizing antibodies
compared to normal antibodies.
The binding preference of a clonal antibody lineage C
to the viral sequence is determined by its site-specific
accessibilities {κCi , κˆCi }, defined in Fig. 1B. The distribu-
tion of site-specific accessibilities over different antibody
lineages PC
({κCi , κˆCi }) characterizes the ability of an anti-
body repertoire to respond to a specific virus. Without
continual introduction of new lineages, one lineage will
ultimately dominate and the rest will go extinct within
the coalescence time-scale of antibodies, Na (Fig. 5A). In
reality, constant turn-over of lineages results in a highly
diverse B-cell response, with multiple lineages acting si-
multaneously against an infection [46].
Stochastic effects are significant when the size of a lin-
eage is small, so an important question is to find the
probability that a low-frequency antibody lineage reaches
an appreciable size and fixes in the population. We de-
note the frequency of an antibody lineage with size NCa
by ρC = NCa /Na. The growth rate of a given lineage C
depends on its relative fitness F
AC compared to the rest
of the population,
d
dt
ρC = (F
AC − FA)ρC +
√
ρC(1− ρC)
Na
χC (10)
where FA =
∑
C FAC ρ
C is the average fitness of the entire
antibody population, and χC is a standard Gaussian noise
term. For the linear fitness landscape from eq. (2), the
mean fitness of lineage C is F
AC = Sa(EC + EˆC). The
probability of fixation of lineage C equals the asymptotic
(i.e., long time) value of the ensemble-averaged lineage
frequency, Pfix(C) = limt→∞〈ρC(t)〉.
Similar to evolution of a single lineage, the dynamics of
a focal lineage are defined by an infinite hierarchy of mo-
ment equations for the fitness distribution. In the regime
of substantial selection, and by neglecting terms due to
mutation, a suitable truncation of the moment hierarchy
allows us to estimate the long-time limit of the lineage
frequency, and hence, its fixation probability (see Sec-
tion E of the Appendix). For an arbitrary fitness func-
tion, fixation probability can be expressed in terms of
the ensemble-averaged relative mean fitness, fitness flux
and transfer flux at the time of introduction of the focal
lineage,
Pfix(C)/P0fix ' 1 +
〈
Na(F
AC (0)− FA(0))
〉
+
N2a
3
〈
φ
AC (0)− φA(0)
〉
−NaNv
〈∣∣T
V→AC (0)
∣∣− ∣∣TV→A(0)∣∣]〉
(11)
where P0fix is the fixation probability of the lineage in
neutrality, which equals its initial frequency at the time
of introduction, P0fix = ρ
C(0). The first order term that
determines the excess probability for fixation of a lineage
is the difference between its mean fitness and the aver-
age fitness of the whole population. Thus, a lineage with
higher relative mean fitness at the time of introduction,
e.g., due to its better accessibility to either the variable
or conserved region, will have a higher chance of fixa-
tion. Moreover, lineages with higher rate of adaptation,
i.e., fitness flux φ
AC (t = 0), and lower (absolute) transfer
flux from viruses
∣∣T
V→AC (t = 0)
∣∣ tend to dominate the
population.
For evolution in the linear fitness landscape, we can
calculate a more explicit expansion of the fixation prob-
ability that includes mutation effects. In this case, the
fixation probability of a focal lineage can be expressed
in terms of the experimentally observable lineage-specific
moments of the binding affinity distribution, instead of
the moments of the fitness distribution (see Section E of
the Appendix).
Emergence of broadly neutralizing antibodies
With our multi-lineage model, we can understand the
conditions for emergence of broadly neutralizing antibod-
ies (BnAbs) in an antibody repertoire. Similar to any
other lineage, the progenitor of a BnAb faces competi-
tion with other resident antibody lineages that may be
dominating the population. The dominant term in the
fixation probability is the relative fitness difference of the
focal lineage to the total population at the time of intro-
duction. Lineages may reach different fitnesses because
they differ in their scale of interaction with the viruses,
EC0 in the variable region and Eˆ
C
0 in the conserved re-
gion; see Section E of the Appendix for details. Lin-
eages which bind primarily to the conserved region, i.e.,
EˆC0  EC0 , are not vulnerable to viral escape mutations
that reduce their binding affinity. Such BnAbs may be
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FIG. 5: Competition between antibody lineages, and
fixation of broadly neutralizing antibodies. (A) Sim-
ulation of competition between 20 clonal antibody lineages
against a viral population. Lineages with higher mean fit-
ness, higher fitness flux, and lower transfer flux tend to dom-
inate the antibody repertoire. Each color represents a dis-
tinct antibody lineage, however there is also diversity within
each lineage from somatic hypermutations. The reduction in
the number of circulating lineages resembles the reduction in
the number of active B-cell clones within the life-time of a
germinal center [8]. Lineages are initialized as 500 random
sequences with random accessibilities κC ’s, unique to each
lineage, drawn from an exponential distribution with rate pa-
rameter 3. Total population sizes are Na = Nv = 10
4. Other
simulation parameters are as specified in the Appendix. (B)
Analytical estimates of the fixation probability Pfix of a new
antibody lineage, based on the state of the populations at the
time of its introduction, compared to Wright-Fisher simula-
tions (points) with two competing antibody lineages. A novel
BnAb (blue) or non-BnAb (red) lineage is introduced at fre-
quency 10% into a non-BnAb resident population (simulation
procedures described in the Appendix). BnAb lineages have
a higher chance of fixing, compared to non-BnAb antibod-
ies, when the viral population is diverse, whereas both types
of Abs have similar chances in the limit of low viral diver-
sity. The solid line is the analytical estimate for Pfix given by
eq. (S140), which is valid when the rate of adaptation is simi-
lar in antibodies and viruses. The dashed line is the analytical
estimate for Pfix using the approximation in eq. (S141), which
is suitable when there is a strong imbalance between the two
populations, as is the case for invasion of a BnAb with strong
antibody selection sa > 1 or against a viral population with
low diversity. In the absence of selection (neutral regime), the
fixation probability of an invading lineage is equal to its initial
frequency of 10%. Panels show different strengths of antibody
selection sa = 0.5, 0.75, 1, 2 against a common viral selection
strength sv = 1. Viral diversity is influenced mostly by the
viral nucleotide diversity θv, which ranges from 0.002 to 0.1.
Other simulation parameters are specified in the Appendix.
able to reach higher fitnesses compared to normal anti-
bodies which bind to the variable region with a compa-
rable scale of interaction. The difference in the mean
fitness of the two lineages becomes even stronger, when
viruses are more diverse (i.e., high MV,2), so that they
can strongly compromise the affinity of the lineage that
binds to the variable region; see eq. (11).
If the invading lineage has the same fitness as the resi-
dent lineage, then the second order terms in eq. (11) pro-
portional to the fitness and transfer flux may be relevant.
A BnAb lineage that binds to the conserved region has
a reduced transfer flux than a normal antibody lineage,
all else being equal. The difference in transfer flux of the
two lineages depends on the viral diversity MV,2, and be-
comes more favorable for BnAbs when the viral diversity
is high. Overall, a BnAb generating lineage has a higher
advantage for fixation compared to normal antibodies,
when the repertoire is coevolving against a highly diver-
sified viral population, e.g., during late stages of HIV
infection.
In Fig. 5B we compare the fixation probability of a
BnAb lineage, that binds only to the conserved region,
with a normal antibody lineage that binds only to
the variable region. In both cases we assume that the
emerging lineage competes against a resident population
of normal antibodies. We compare our analytical
predictions for fixation probability as a function of the
initial state of the antibody and viral populations in
eqs. (S140, S141), with Wright-Fisher simulations of
coevolving populations (numerical procedures detailed
in Section G of the Appendix). Increasing viral diversity
M2,V increases the fixation of BnAbs, but does not
influence fixation of normal lineages. For low viral
diversity, fixation of BnAbs is similar to normal Abs,
and therefore they might arise and be outcompeted by
other antibody lineages.
Discussion
We have presented an analytical framework to describe
coevolutionary dynamics between two antagonistic pop-
ulations based on molecular interactions between them.
We have focused our analysis on antibody-secreting B-
cells and chronic infections, such as HIV. We identi-
fied effective parameters for selection on B-cells during
hypermutation that enhance their binding and neutral-
ization efficacy, and conversely parameters for selection
on viruses to escape antibody binding. The resulting
“red-queen” dynamics between antibodies and viruses
produces a characteristic signature of coevolution in our
model, i.e., viruses are resistant to antibodies from the
past and are susceptible to antibodies from the future.
We used our results to infer modes of immune-viral co-
evolution based on time-shifted neutralization measure-
ments in two HIV-infected patients. Finally, we have
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shown that emergence and fixation of a given clonal an-
tibody lineage is determined by competition between cir-
culating antibody lineages, and that broadly neutralizing
antibody lineages, in particular, are more likely to dom-
inate in the context of a diverse viral population.
Luo and Perelson [30] found that competition between
lineages caused BnAbs to appear late in their simula-
tions. In addition, they found that multiple viral founder
strains dilutes the competition of BnAbs with specific an-
tibodies, leading to higher chance of BnAb appearance.
The assumptions of their simulations differ in many ways
from those of our model, and yet their overall finding
agrees with our analytical results: BnAbs fix more read-
ily when there is a large diversity of viral binding. In
contrast to Luo and Perelson’s simulations which made
assumptions about the immunogenicity of BnAbs, our
analytic results show explicitly how differences in fitness
of antibodies and the efficacy of viral escape affect com-
petition between antibody lineages.
Our model is simple enough to clarify some fundamen-
tal concepts of antibody-antigen dynamics. However, un-
derstanding more refined aspects of B-cell-virus coevolu-
tion will require adding details specific to affinity mat-
uration and viral reproduction, such as non-neutralizing
binding between antibodies and antigens [15, 47], epi-
tope masking by antibodies [48] and spatial structure
of germinal centers [8]. Importantly, viral recombina-
tion [37, 38, 49] and latent viral reservoirs [50] are also
known to influence the evolution of HIV within a pa-
tient. Similarly, the repertoire of the memory B-cells
and T-cells, which effectively keep a record of prior vi-
ral interactions, influence the response of the adaptive
immune system against viruses with antigenic similarity.
While our analysis has focused on coevolution of
chronic viruses with the immune system, our frame-
work is general enough to apply to other systems, such
as bacteria-phage coevolution. Likewise, the notions
of fitness and transfer flux as measures of adaptation
are independent of the underlying model. Bacteria-
phage interactions have been studied by evolution ex-
periments [51, 52], and by time-shifted assays of fit-
ness [53, 54], but established models of coevolution typ-
ically describe only a small number of alleles with large
selection effects [55]. In contrast, our model offers a for-
malism for bacteria-phage coevolution where new geno-
types are constantly produced by mutation, consistent
with experimental observations [53]. Similarly, our for-
malism may be applied to study the evolution of seasonal
influenza virus in response to the “global” immune chal-
lenge, imposed by a collective immune landscape of all
recently infected or vaccinated individuals. Time-shifted
binding assays of antibodies to influenza surface pro-
teins are already used to gauge the virulence and cross-
reactivity of viruses [56]. Quantifying the fitness flux and
transfer flux, based on these assays, is therefore a princi-
pled way to measure rates of immunologically important
adaptation in these systems.
One central challenge in HIV vaccine research is to
devise a means to stimulate a lineage producing broadly
neutralizing antibodies. Common characteristics of
BnAbs, such as high levels of somatic mutation or large
insertions, often lead to their depletion by mechanisms of
immune tolerance control [57]. Therefore, one strategy
to elicit these antibodies is to stimulate the progeni-
tors of their clonal lineage, which may be inferred by
phylogenetic methods [58], and to guide their affinity
maturation process towards a broadly neutralizing state.
Understanding the underlying evolutionary process is
necessary to make principled progress towards such
strategies, and this study represents a step in that di-
rection. For example, our results suggest that a vaccine
based on a genetically diverse set of viral antigens is
more likely to stimulate BnAbs.
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Appendix
A. Antibody-viral coevolution in genotype space
We represent the antibody population as a set of k genotypes consisting of vectors, Aα (α = 1 . . . k), and corre-
sponding genotype frequencies x, with elements xα satisfying
∑k
α=1 x
α = 1. Similarly, we consider a viral population
with k′ possible genotypes Va, and frequencies y with elements yγ (γ = 1, . . . , k′) with
∑k′
γ=1 y
γ = 1. Note that
superscripts are indices, not exponentiation, unless next to parentheses, e.g. (a)b. The frequencies change over time,
although we omit explicit notation for brevity, and hence every quantity that depends on the frequencies is itself
time-dependent. In the following, we describe separately contributions from three evolutionary forces (i) mutation,
(ii) selection, and (iii) genetic drift, and build a general stochastic framework for coevolution of antibodies and viruses
in the space of genotypes. We assume that population sizes are large enough, and changes in frequencies are small
enough to accommodate a continuous time and continuous frequency stochastic process [59, 60].
(i) Mutations. The change of the genotype frequencies due to mutations follow,
dxα
dt
= m
Aα
(x) ≡
k∑
β=1
µ
Aβ→Aαx
β −
 k∑
β=1
µ
Aα→Aβ
xα
dyγ
dt
= m
V γ
(y) ≡
k′∑
λ=1
µ
V λ→V γ y
λ −
 k′∑
λ=1
µ
V γ→V λ
 yγ
(S1)
where we define m
Aα
and m
V γ
as the genotype-specific components of the mutational fields in the antibodies and
viruses, and µ
Aβ→Aα is the antibody mutation rate from genotype A
β to Aα, and similarly, µ
V λ→V γ is the viral
mutation rate from the genotype Vλ to Vγ . We assume constant mutation rates µa, µv, per generation per site for
antibodies and viruses, with the exception of µv = 0 for the viral constant region, which implies that mutations in
that region are lethal for the virus.
(ii) Selection and interacting fitness functions. The fitness of a genotype determines its growth rate at each
point in time. We define fitness of genotypes in one population as a function of the genotypes in the other population.
The general form of change in genotype frequencies due to selection follows,
1
xα
dxα
dt
= f
Aα
(x; y)−
∑
α
xαf
Aα
(x; y)
1
yγ
dyγ
dt
= f
V γ
(y; x)−
∑
γ
yγf
V γ
(y; x)
(S2)
The subscript for the antibody and viral fitness functions, f
Aα
(x; y) and f
V γ
(y; x), refer to the genotypes in the
corresponding population. The explicit conditional dependence of the antibody fitness function f
Aα
(x; y) on the
viral frequency vector y emphasizes that fitness of an antibody depends on the interacting viral population {V}.
Similar notation is used for the fitness function of the viruses. The subtraction of the population’s mean fitness,
F
A
=
∑
α x
αf
Aα
(x; y) and F
V
=
∑
γ y
γf
V γ
(y; x), ensures that the genotype frequencies remain normalized in each
population. In terms of linearly independent frequencies x = (x1, . . . , xk−1) and y = (y1, . . . , yk
′−1), these evolution
equations take the forms,
dxα
dt
=
∑
antibodies: β
gαβ σ
Aβ
(x; y),
dyγ
dt
=
∑
viruses: λ
hγλ σ
V λ
(y; x)
(S3)
where σ
Aα
(x; y) = f
Aα
(x; y) − fAk(x; y) and σV γ (y; x) = fV γ (y; x) − fV k′ (y; x) are the respective time-dependent
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selection coefficients of the antibody Aα and the viral strain Vγ , which depend on the state of the both populations
at that moment in time. The inverse of the response matrices, gαβ = (g
αβ)−1 and hγλ = (hγλ)−1, play the role of
metric in the genotype space (see below and e.g., [61]). The change in the mean fitness due to selection after an
infinitesimal amount of time follows,
F
A
(x + δx; y + δy) =
∑
α
σ
Aα
(x; y)δxα +
∑
γ,α
xα σ
V γ→Aα (x; y) δy
γ (S4)
F
V
(y + δy; x + δx) =
∑
γ
σ
V γ
(y; x)δyγ +
∑
γ,α
yγ σ
Aα→V γ (y; x) δx
α (S5)
where δxα and δyγ are the infinitesimal changes in the genotype frequencies, and σ
V γ→Aα = ∂σAα /∂y
γ and, σ
Aα→V γ =
∂σ
V γ
/∂xα are respectively the change in the selection coefficient of the antibody Aα and the virus Vγ due the evolution
of opposing population. This measure of fitness transfer is a useful concept for interacting populations. Intuitively, it
can be understood as the change of fitness in one population only due to the changes of allele or genotype frequencies
in the opposing population.
(iii) Genetic drift and stochasticity. The stochasticity of reproduction and survival, commonly known as genetic
drift, is represented as discrete random sampling of offspring genotypes from the parent’s generation with the constraint
that the total population size remains constant. The magnitude of this sampling noise is proportional to inverse
population size. Na and Nv are the effective population sizes of the antibody and the viral populations, which
represent the size of population bottlenecks e.g., in a germinal center. In the continuous time, continuous frequency
limit, genetic drift is represented as noise terms in a diffusion equaiton with magnitude proportional to inverse
population size [60]. The diffusion coefficients are characteristics of the Fisher metric [61, 62],
gαβ =
{
−xαxβ if α 6= β
xα(1− xα) if α = β , h
γλ =
{
−yγyλ if γ 6= λ
yγ(1− yγ) if γ = λ
(S6)
The generalized Kimura’s diffusion equation [63] for the joint distribution of genotype frequencies P (x,y, t) in both
populations reads,
∂
∂t
P (x,y, t) =
∑
α,β,γ,λ
[ 1
2Na
∂2
∂xαxβ
gαβ(x) +
1
2Nv
∂2
∂yγ∂yλ
hγλ(y)
+
∂
∂xα
(
mα
A
(x) + gαβ(x)σ
Aβ
(x; y)
)
+
∂
∂yγ
(
mγ
V
(y) + hγλ(y)σ
V λ
(y; x)
)]
P (x,y, t)
(S7)
This Fokker-Planck equation acts on the high-dimensional genotype space of antibodies and viruses, which are
likely to be under-sampled in any biological setting. In the following, we introduce a projection from genotype space
onto a lower dimensional space of molecular traits (phenotypes) to make the problem tractable.
B. Antibody-viral coevolution in phenotype space
B.1 Molecular phenotypes for antibody-viral interaction
We define the binding affinity between an antibody and viral genotype as the molecular interaction phenotype
under selection, for which we describe the evolutionary dynamics. Antibody and viral genotypes are represented by
binary sequences of ±1. Antibody sequences are of length `+ ˆ`, while viral sequences consist of a mutable region of
length `, and a conserved (i.e. sensitive) region of length ˆ`, where each site is always +1, as was similarly done in
[27]. We model the binding affinity between antibody Aα and virus Vγ as a weighted dot product over all sites,
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Etot(A
α,Vγ) =
∑`
i=1
κiA
α
i V
γ
i +
`+ˆ`∑
i=`+1
κˆiA
α
i
≡ Eαγ + Eˆα (S8)
where Aαi , and V
γ
i denote the i
th site in antibody Aα and virus Vγ , respectively. The set of coupling constants for
the mutable and conserved region, {κi, κˆi ≥ 0} represent the accessibility of a clonal antibody lineage to regions of
the viral sequence. Matching bits at interacting positions enhance binding affinity between an antibody and a virus.
Similar models have been used to describe B-cell maturation in germinal centers [27], and T-cell selection based on
the capability to bind external antigens and avoid self proteins [35, 36]. In Section , we extend our model to multiple
lineages, where each lineage has its own set of accessibilities. Antibody lineages with access to the conserved regions
of the virus can potentially fix as broadly neutralizing antibodies. We denote the quantities related to the conserved
sites of the virus with a hat: ·ˆ.
We project the evolutionary forces acting on the genotype to the binding phenotype Etot, and quantify the
changes of the binding phenotype distribution in each population over time. For a single antibody genotype Aα we
characterize its interactions with the viral population by the genotype-specific moments,
Statistics of the binding affinity distribution for antibody Aα:
(i) average in the variable region:
Eα . =
∑
γ∈ viruses
Eαγy
γ (S9)
(ii) average in the conserved region:
Eˆα . = Eˆα (S10)
(iii) rth central moment in the variable region:
I(r)α . =
∑
γ∈ viruses
(Eαγ − Eα .)ryγ (S11)
Since the viral population is monomorphic in the conserved region, the average mean binding affinity of an
antibody is independent of the state of the viral population, Eˆα . = Eˆα, and the higher central moments are zero,
Iˆ
(r)
α . = 0. Similarly, we characterize the interactions of a given viral genotype Vγ with the antibody population,
Statistics of the binding affinity distribution for virus Vγ:
(i) average in the variable region:
E. γ =
∑
α∈antibodies
Eαγx
α (S12)
(ii) average in the conserved region:
Eˆ. γ =
∑
α∈antibodies
Eˆαx
α ≡ Eˆ. (S13)
(iii) rth central moment in the variable region:
I(r). γ =
∑
α∈antibodies
(Eαγ − E. γ)rxα (S14)
(iii) rth central moment in the conserved region:
Iˆ(r). γ =
∑
α∈antibodies
(Eˆα − Eˆ)rxα (S15)
One of the most informative statistics that we characterize is the distribution of population-averaged antibody and
viral binding interactions, respectively denoted by PA(Eα ., Eˆα) and PV (E. γ , Eˆ.). The mean of these distributions
are equal to each other, but the higher moments differ. We denote the population-specific moments of the average
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interactions by,
Mean binding affinity in,
(i) the variable region: E =
∑
α,γ
Eαγ x
αyγ (S16)
(ii) the conserved region: Eˆ =
∑
α
Eˆα x
α (S17)
rth central moment of the average affinities in,
(i) the variable region of antibody population:
MA,r =
∑
α∈antibodies
(Eα . − E)rxα (S18)
(ii) the conserved region of antibody population:
MˆA,r =
∑
α∈antibodies
(Eˆα . − Eˆ)rxα (S19)
(iii) the variable region of viral population:
MV,r =
∑
γ∈viruses
(E. γ − E)ryγ (S20)
Note that the population central moments MA,r and MV,r are distinct from the genotype-specific moments, I
(r)
α .
and I
(r)
. γ . The central moments of the viral population in the conserved region are equal to zero, MˆV,r = 0.
Trait scale and dimensionless quantities. It is useful to measure phenotypes in natural units, which avoids the
arbitrariness of the physical units ({κi, κˆi}), and the total number of sites ` + ˆ`. As previously shown in [34, 64],
there exist summary statistics of the site-specific effects, (here {κi, κˆi}), which define a natural scale of the molecular
phenotype. We denote the moments of the site-specific effects along the genome by,
Kr = 1
`
∑`
i=1
(κi)
r, Kˆr = 1ˆ`
`+ˆ`∑
i=`+1
(κˆi)
r (S21)
We express the phenotype statistics in units of the trait scales, i.e., the squared sum of the site-specific effects,
E20 = K2` in the variable region, and Eˆ20 = Kˆ2 ˆ` in the conserved region. The rescaled phenotype statistics follow,
ε ≡ E
E0
, εˆ ≡ E
Eˆ0
and, mZ,r ≡ MZ,r
Er0
, mˆZ,r ≡ MˆZ,r
Eˆr0
(for Z = A, V ) (S22)
These scaled values are pure numbers (we distinguish them by use of lower case letters from the raw data). The
trait scales E20 and Eˆ
2
0 provide natural means to standardize the relevant quantities because they are the stationary
ensemble variances of the population mean binding affinity in an ensemble of genotypes undergoing neutral evolution
in the weak-mutation regime (see Section B.3 for derivation of the stationary statistics),
E20 = lim
µv,µa→0
〈(E − 〈E〉)2〉, Eˆ20 = lim
µa→0
〈(Eˆ − 〈Eˆ〉)2〉 (S23)
where 〈·〉 indicates averages over an ensemble of independent populations.
Binding probability. The probability that an antibody is bound by an antigen determines its chance of proliferation
and survival during the process of affinity maturation, and hence, defines its fitness. We describe two distinct models
for antibody activation. The simplest model assumes that the binding probability of a given antibody Aα is a sigmoid
function of its mean binding affinity against the viral population,
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p
A
(Aα) =
1
1 + exp[−β0(Eα . + Eˆα . − E∗)]
(S24)
where E∗ is the threshold for the binding affinity and β0 determines the amount of nonlinearity, and is related to the
inverse of temperature in thermodynamics. Following the rescaling introduced in eq. (S22), the binding threshold
and the nonlinearity in eq. (S24) rescale as e∗ ≡ E∗/
√
Eˆ20 + E
2
0 and β = β0
√
Eˆ20 + E
2
0 . In the following, we will use
eq. (S24) to characterize a biophysically grounded fitness function for antibodies.
For the virus, binding to an antibody reduces the chances of its survival. Similar to eq. (S24), the probability that
a given virus Vγ is bound by antibodies follows,
p
V
(Vγ) =
1
1 + exp[−β0(E. γ + Eˆ. γ − E∗)]
, (S25)
where E∗ and β0 are similar to eq. (S24).
In Section B.5, we will discuss an alternative model for activation of an antibody which is based on its strongest
binding affinity with a subset of viruses.
B.2 Coevolutionary forces on the binding affinity
Similar to genotype evolution, stochastic evolution of a molecular phenotype generates a probability distribution,
Q(E , Eˆ ,MA,r, MˆA,r,MV,r), which describes an ensemble of independently evolving populations, each having a pheno-
type distribution with mean affinity E and Eˆ and central moments of the averaged affinity in the antibody population,
MA,r, MˆA,r, and in the viral population, MV,r (see also [64]). The probability distribution Q(E , Eˆ ,MA,r, MˆA,r,MV,r)
can be expressed in therms of the distribution for genotype frequencies,
Q(E , Eˆ ,MA,r, MˆA,r,MV,r) =∫
dxdyP (x,y, t)
[
δ(E(x,y)− E) δ(Eˆ(x)− Eˆ)
∏
r
δ(MA,r(x,y)−MA,r) δ(MˆA,r(x)− MˆA,r) δ(MV,r(x,y)−MV,r)
]
(S26)
where δ(·) is the Dirac delta function. Below, we characterize the effect of mutations, selection and genetic drift on
the evolution of the phenotype moments E , MA,r, MˆA,r and MV,r.
Mutation. A mutation at site “i” changes the sign of the site, and its effect on the binding affinity is proportional
to κi in the variable region, and κˆi in the conserved region. To compute the effect of mutations on moments of the
phenotype distribution, we classify pairs of genotypes (Aα,Vγ) in mutational classes, defined by the number of +1
positions of their product vector (Aα1 · V γ1 , . . . , Aα`+ˆ` · V
γ
`+ˆ`
), which we denote by n+ in the variable region and by nˆ+
in the conserved interaction region,
n+(A
α,Vγ) =
∑`
i=1
δ(1−Aαi · V γi ), nˆ+(Aα,Vγ) =
`+ˆ`∑
i=`+1
δ(1−Aαi · V γi ) (S27)
The frequency of each mutational class Q(n+) is estimated from interactions between all pairs of antibody and viral
genotypes in both variable and conserved regions of the interacting populations,
Q(1)(n+) = 1
NaNV
∑
α,γ
δ(n+(A
α,Vγ)− n+), Q(2)(n+) = 1
NaNV
∑
α,γ
δ(nˆ+(A
α,Vγ)− nˆ+) (S28)
The superscript λ = 1, 2 indicates the interacting region of the virus, i.e. λ = 1 refers to the variable region of the
virus with µ
(1)
v = µv and the length `
(1) = `, and λ = 2 refers to the conserved region of the viral genome with µ
(2)
v = 0
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and the sequence length `(2) = ˆ`. If the mutational effects of all sites were equal to κ, phenotype moments could be
simply expressed using the statistics of mutational classes: e.g., E = (2[n+]A,V − `)κ, where [·]A,V indicates averaging
of a quantity in the subscript populations, which in this case are both the viral and the antibody populations. If the
number of encoding sites of a phenotype is large, annealed averages of the heterogeneous site-specific contributions
Kr, Kˆr can well approximate the the moments of the phenotype distribution [64–66]. As a result, the statistics of the
variable region follow, E = (2[n+]A,V − `)K1 for the mean binding affinity, and MV,r = 2rKr
[(
[n+]A − [n+]A,V
)r]
V
,
MA,r = 2
rKr
[(
[n+]V − [n+]A,V
)r]
A
for the higher central moments in viruses and antibodies. Similar expressions
can be derived for the statistics of the conserved region. Therefore, evolution of the phenotype distribution can be
well-approximated using projections from evolutionary dynamics of the mutational classes. The Master equation for
the evolution of the mutational classes under neutrality (mutation and genetic drift) follows,
dQ(λ)(n+) = (µa + µ(λ)v )
[
(`(λ) − (n+ − 1))Q(λ)(n+ − 1) + (n+ + 1)Q(λ)(n+ + 1)− `(λ)Q(λ)(n+)
]
dt
+
(
δn′+,n+ −Q(λ)(n+)
)√Q(λ)(n+)
Na
dW
A
(t) +
√
Q(λ)(n+)
Nv
dW
V
(t)
 (S29)
W
A
(t) and W
V
(t) are delta-correlated Gaussian noise (Wiener process) with an ensemble mean 〈Wi〉 = 0 and
variance, 〈Wi(t)Wj(t′)〉 = δi,j δ(t− t′) where i, j ∈ {A, V } indicate antibodies and viruses. The stochasticity (genetic
drift) is due to finite population size of the interacting genotypes Na and Nv.
In neutrality, the ensemble mean for the averaged number of positive sites
〈
[n+
(λ)]
A,V
〉
and the central moments,〈
Y
(λ)
A,r
〉 ≡ 〈[([n(λ)+ ]V − [n(λ)+ ]A,V )r]
A
〉
and 〈Y (λ)V,r 〉 ≡
〈[(
[n
(λ)
+ ]A− [n(λ)+ ]A,V
)r]
V
〉
in both variable (λ = 1) and conserved
(λ = 2) interaction regions follow [65, 66],
∂〈[n+(λ)]A,V 〉
∂t
=
〈
(µa + µ
(λ)
v )
∑
n+
n+
[
(`(λ) − n+ + 1)Q(λ)(n+ − 1) + (n+ + 1)Q(λ)(n+ + 1)− `(λ)Q(λ)(n+)
]〉
=

−2(µa + µv)
[
(
〈
[n+]A,V
〉− `/2) variable region, λ = 1
−2µa
( 〈
[n+]A,V
〉− ˆ`/2) constant region, λ = 2 (S30)
∂
∂t
〈
Y
(λ)
A,r
〉
= µa`
(λ)
r−2∑
i=0
(
r
i
)〈
Y
(λ)
A,i
〉
+
(
r
2
) 〈
Y
(λ)
A,2Y
(λ)
A,r−2
〉
− r
〈
Y
(λ)
A,r
〉
Na
− 2r(µa + µ(λ)v )
〈
Y
(λ)
A,r
〉
−µa
r−2∑
i=0
(
r
i
)(〈
Y
(λ)
A,i+1
〉
+
〈
[n+]A,V Y
(λ)
A,i
〉)
[1 + (−1)r−i+1] (S31)
∂
∂t
〈
Y
(λ)
V,r
〉
= µ(λ)v `
(λ)
r−2∑
i=0
(
r
i
)〈
Y
(λ)
V,i
〉
+
(
r
2
) 〈
Y
(λ)
V,2 Y
(λ)
V,r−2
〉
− r
〈
Y
(λ)
V,r
〉
Nv
− 2r(µa + µ(λ)v )〈Y (λ)V,r 〉
−µ(λ)v
r−2∑
i=0
(
r
i
)(〈
Y
(λ)
V,i+1
〉
+
〈
[n+]A,V Y
(λ)
V,i
〉)
[1 + (−1)r−i+1] (S32)
where 〈·〉 denotes averages over independent ensembles of populations. The second term in the right-hand side of
equations (S31, S32) is a consequence of the Itoˆ calculus in stochastic processes [59]. The transformations from
[n
(1)
+ ]A,V to E in the variable region, and from [n(2)+ ]A,V to Eˆ in the conserved region result in,
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∂〈E〉
∂t
= −2(µa + µv)〈E〉 (S33)
∂〈Eˆ〉
∂t
= −2µa〈Eˆ〉 (S34)
The transformations from Y
(1)
A,r to MA,r, from Y
(2)
A,r to MˆA,r and from Y
(1)
V,r to MV,r result in,
∂〈MA,r〉
∂t
= µa`
r−2∑
i=0
2r−iKr−i
(
r
i
)
〈MA,i〉+
(
r
2
)K2Kr−2〈MA,2MA,r−2〉 − r〈MA,r〉
Na
− 2r(µa + µv)〈MA,r〉
−µa
r−2∑
i=0
2r−i−1
(
r
i
)[
Kr−i−1〈MA,i+1〉+ Kr−iK1
〈EMA,i〉] [1 + (−1)r−i+1]
(S35)
∂〈MˆA,r〉
∂t
= µa ˆ`
r−2∑
i=0
2r−iKr−i
(
r
i
)
〈MˆA,i〉+
(
r
2
)K2Kr−2〈MˆA,2MˆA,r−2〉 − r〈MˆA,r〉
Na
− 2rµa〈MˆA,r〉
−µa
r−2∑
i=0
2r−i−1
(
r
i
)[
Kr−i−1〈MˆA,i+1〉+ Kr−iK1
〈EˆMˆA,i〉] [1 + (−1)r−i+1]
(S36)
∂〈MV,r〉
∂t
= µv`
r−2∑
i=0
2r−iKr−i
(
r
i
)
〈MV,i〉+
(
r
2
)K2Kr−2〈MV,2MV,r−2〉 − r〈MV,r〉
Nv
− 2r(µv + µa)〈MV,r〉
−µv
r−2∑
i=0
2r−i−1
(
r
i
)[
Kr−i−1〈MV,i+1〉+ Kr−iK1
〈EMV,i〉] [1 + (−1)r−i+1]
(S37)
Selection. We assume that (malthusian) fitness of an antibody is proportional to the logarithm of its activation
probability given by eq. (S24) based on its average interaction strength,
f
Aα
≡ f
A
(Aα; {V }) = ca log[pA(Aα)] = −ca log(1 + exp[−β0(Eα . + Eˆα . − E∗)]) (S38)
' f∗
A
+ Sa(Eα . + Eˆα .) (S39)
with f∗
A
= −ca log
(
1 + exp[β0E
∗]
)
and the selection coefficient Sa = caβ0/(1 + exp[−β0E∗]). The approximation
in (S39) is by expansion of the nonlinear fitness function around the neutral binding affinity, E = 0. The antibody
selection coefficient Sa can be thought as the amount of stimulation that a bound B-cell receptor experiences, e.g.
due to helper T-cells. If the chronic infection is HIV, where the virus attacks the helper T-cells, Sa may decrease as
HIV progresses and the T-cell count decays. Furthermore, f∗
A
affects the absolute growth rate, but does not affect
the relative growth rate between genotypes. We call the fitness models based on the averaged binding affinity in
eq. (S38) as nonlinear-averaged and in eq. (S39) as linear-averaged. In Section B.5 we introduce an alternative model
of antibody activation, which assumes that proliferation of an antibody is related to its best binding affinity against
R ≤ Nv antigens, that are presented to the antibody during its life time. The analytical results in this paper are
all based on the antibody evolution in linear-averaged fitness landscapes (S39), and the other fitness models are only
studied numerically.
The viral fitness is related to the probability that it escapes the binding interactions with antibodies. We define
the fitness of an antigen (virus) as the negative logarithm of its binding probability to the average antibodies that it
interacts with, given by eq. (S25),
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f
V γ
≡ f
V
(Vγ ; {A}) = −cv log[pV (Vγ)] = cv log(1 + exp[−β0(E. γ + Eˆ. γ − E∗)]) (S40)
' f∗
V
− Sv(E. γ + Eˆ. γ) (S41)
with f∗
V
= cv log
(
1 + exp[β0E
∗]
)
and the selection coefficient Sv = cvβ0/(1 + exp[−β0E∗]).
As shown in eq. (S3) the change in the frequency of an antibody or a virus is proportional to its fitness, which is
related to its average binding affinity. Therefore, the change of a given phenotype statistic U(x,y) due to selection
follows,
d
dt
U(x,y) =
∑
α,γ
[
∂U
∂xα
(f
Aα
− F
A
)xα +
∂U
∂yγ
(f
V γ
− F
V
) yγ
]
(S42)
where F
A
and F
V
are respectively the mean fitness in the antibody and in the viral population. With this formulation
we can compute the effect of selection on the statistics of the binding affinity distribution, i.e., the mean affinity E ,
Eˆ , and the central moments, MA,r, MˆA,r and MV,r, which we present in the following section.
Similar to the rescaling procedure in eq. (S22), we use the total trait scales to define the rescaled strength of
selection,
sa = NaSaE0, sˆa = NaSaEˆ0, sv = NaSvE0, sˆv = NvSvEˆ0 (S43)
Genetic drift. We can project the stochasticity of the genotype space onto the phenotype space. The projected
diffusion coefficients show the correlation between the noise levels of the phenotypic statistics A and B.
GAB = 1
Na
∑
α,β
∂A
∂xα
∂B
∂xβ
gαβ +
1
Nv
∑
γ,λ
∂A
∂yγ
∂B
∂yλ
hγλ (S44)
and the genotypic diffusion constants gαβ and hγλ are given by eq. (S6). As an example, we compute the diffusion
term for the mean binding affinity in the variable region E ,
GEE = 1
Na
∑
α,β
∂E
∂xα
∂E
∂xβ
gαβ +
1
Nv
∑
γ,λ
∂E
∂yγ
∂E
∂yλ
hγλ
=
1
Na
∑
α,β
Eα .Eβ .
[
− xαxβ(1− δαβ) + xα(1− xα)δαβ
]
+
1
Nv
∑
γ,λ
E. γE. λ
[
− yγyλ(1− δλγ ) + yγ(1− yγ)δλγ
]
=
1
Na
[∑
α
(Eα . − E)2xα
]
+
1
Nv
[∑
γ
(E. γ − E)2yγ
]
=
1
Na
MA,2 +
1
Nv
MV,2 (S45)
where δαβ is a Kronecker delta function. A similar approach finds the diffusion terms for the second moments and
the cross-correlation terms between the first and the second moments in the variable and the conserved regions (see
e.g., [64] for further details),
GMA,2,MA,2 = 1
Na
(MA,4 −M2A,2), GMV,2,MV,2 =
1
Nv
(MV,4 −M2V,2), GMˆA,2,MˆA,2 =
1
Na
(MˆA,4 − Mˆ2A,2)
(S46)
GE,MA,2 = 1
Na
MA,3, GE,MV,2 = 1
Nv
MV,3, GEˆ,MˆA,2 = 1
Na
MˆA,3
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B.3 Stochastic evolution of molecular phenotypes (linear-averaged fitness)
Putting all the evolutionary forces together, we can write down evolution equations for the statistics of binding
affinities in a linear fitness landscape introduced in equations (S39, S41),
variable region:
d
dt
E = −2(µv + µa)E + SaMA,2 − SvMV,2 + χE (S47)
conserved region:
d
dt
Eˆ = Sa MˆA,2 − 2µa Eˆ + χEˆ (S48)
with the Gaussian correlated noise statistics due to the genetic drift,
〈χE〉 = 0, 〈χE(t)χE(t′)〉 =
[MA,2
Na
+
MV,2
Nv
]
δ(t− t′) (S49)
〈χEˆ〉 = 0, 〈χEˆ(t)χEˆ(t′)〉 =
[MˆA,2
Na
]
δ(t− t′) (S50)
Similarly, we can write down the stochastic evolution equations for the second moments MA,2, MˆA,2 and MV,2,
d
dt
MA,2 = −4µa(MA,2 − `K2)− 4µvMA,2 − MA,2
Na
+ SaMA,3 + χMA,2 (S51)
d
dt
MˆA,2 = −4µa(MˆA,2 − ˆ`Kˆ2)− MˆA,2
Na
+ SaMˆA,3 + χMˆA,2 (S52)
d
dt
MV,2 = −4µv(MV,2 − `K2)− 4µaMV,2 − MV,2
Nv
− SvMV,3 + χMV,2 (S53)
with Gaussian correlated noise statistics,
〈χ
MA,2
〉 = 0, 〈χ
MA,2
(t)χ
MA,2
(t′)〉 =
[
MA,4 − (MA,2)2
Na
]
δ(t− t′) (S54)
〈χ
MˆA,2
〉 = 0, 〈χ
MˆA,2
(t)χ
MˆA,2
(t′)〉 =
[
MˆA,4 − (MˆA,2)2
Na
]
δ(t− t′) (S55)
〈χ
MV,2
〉 = 0, 〈χ
MV,2
(t)χ
MV,2
(t′)〉 =
[
MV,4 − (MV,2)2
Nv
]
δ(t− t′) (S56)
〈χ
MA,2
(t)χE(t′)〉 = MA,3
Na
δ(t− t′), 〈χ
MˆA,2
(t)χEˆ(t
′)〉 = MˆA,3
Na
δ(t− t′) (S57)
〈χ
MV,2
(t)χE(t′)〉 = 〈MV,3〉
Nv
δ(t− t′) (S58)
It should be noted that we ignore the linkage correlations between the binding affinity of the variable region
E and conserved region Eˆ of the virus. From the numerical analysis we see that the covariance between the
linked variable and conserved regions, 〈∑α xα(Eα . − E) (Eˆα − Eˆ)〉 is small compared to the diversity of the average
binding affinity in both regions of antibody and viral populations, 〈MA,2〉, 〈MˆA,2〉 and 〈MV,2〉; S2D Fig. Lineages
with access to the conserved region of the virus adapt by aligning their sites to the conserved sequence, and
hence, remain relatively conserved with variations arising only from the stochastic forces of mutation and genetic
drift. In Section B.4 we explicitly show that the auto-correlation time for the binding affinity in the conserved
region is longer than in the variable interaction region; see equations (S82, S81). Therefore, the correlation be-
tween the binding affinity of the variable and the conserved regions remains small throughout the evolutionary process.
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FIG. S1: Effect of selection on the mean binding affinity. The rescaled mean binding affinity for (A) the variable
interaction region ε = E/E0, and (B) the conserved region εˆ = Eˆ/E0, as a function of selection coefficients. Stationary
mean binding affinity is sensitive to selection on antibodies in both variable and conserved regions. The conserved region is
not sensitive to viral selection strength. Points indicate simulation results, dashed lines indicate the stationary solution in
eqs. (S59, S61) using estimates for the diversity of the binding affinity from the simulations, and solid lines are the stationary
solutions (S59, S61) using the analytical estimates of the diversity from eq. (S75). Parameters are: κi = κˆi = 1 for all sites,
` = ˆ` = 50, Na = Nv = 1000, θa = θv = 1/50. Points are time averaged values from simulations run for 10
6Na generations,
with values sampled every Na generations, and data from first 100Na generations discarded.
Stationary solutions for trait mean and diversity. From equations above we can solve for the stationary mean
binding affinity, binding diversity in both populations, and the covariance between the moments as a function of the
higher moments,
〈E〉 = 1
2(θa + θ˜v)
NaSa〈MA,2〉 − 1
2(θ˜a + θv)
NvSv〈MV,2〉 (S59)
〈E , E〉 = 1
4(θa + θ˜v)
[〈MA,2〉+ 2NaSa〈E ,MA,2〉]+ 1
4(θ˜a + θv)
[〈MV,2〉 − 2NvSv〈E ,MV,2〉] (S60)
〈Eˆ〉 = NaSa〈MˆA,2〉/2θa (S61)
〈Eˆ , Eˆ〉 = 1
4θa
[〈MˆA,2〉+ 2NaSa〈Eˆ , MˆA,2〉] (S62)
〈
MA,2
〉
=
1
1 + 4(θa + θ˜v)
[
4`K2θa + (NaSa) 〈MA,3〉
]
(S63)
〈
MV,2
〉
=
1
1 + 4(θ˜a + θv)
[
4`K2θv − (NvSv) 〈MV,3〉
]
(S64)
〈E ,MA,2〉 = 1
1 + 6(θa + θ˜v)
[
〈MA,3〉+NaSa
[〈E ,MA,3〉+ 〈(MA,2)2〉]) (S65)
〈E ,MV,2〉 = 1
1 + 6(θ˜a + θv)
(
〈MV,3〉 −NvSv
[〈E ,MV,3〉+ 〈(MV,2)2〉]) (S66)
〈E ,MA,3〉 = 〈MA,4〉/3− 〈(MA,2)
2〉
1 + 8/3(θa + θ˜v)
, 〈E ,MV,3〉 = 〈MV,4〉/3− 〈(MV,2)
2〉
1 + 8/3(θ˜a + θv)
(S67)
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FIG. S2: Effect of selection on the diversity and covarinace of binding affinity in antibodies and viruses. Stationary
diversity of the binding affinity for (A) the variable interaction region mA,2 = MA,2/E
2
0 , (B) the conserved interaction region
mˆA,2 = MˆA,2/Eˆ
2
0 in the antibody population, and (C) the variable region in the viral population mV,2 = MV,2/E
2
0 plotted as
a function of viral and antibody selection coefficients. The diversity of binding across the antibodies in the conserved region
mˆA,2 in (B) is not sensitive to viral selection strength. (D) The magnitude of the rescaled covariance due to genetic linkage
between binding of the antibody to the conserved and the variable regions, 〈[(Eα . − E)(Eˆα . − Eˆ)]A〉/E0Eˆ0, is much smaller
than the diversity of binding in each region, shown in (A) and (B). Points indicate simulation results with parameters similar
to Fig. S1, dashed lines indicate the stationary solution using estimates for higher moments from the simulations (eqs. (S63,
S64)), and solid lines indicate the full stationary solution given by eq. (S75) for antibodies, and the corresponding solution for
viruses. Theory lines begin to deviate from simulation results for large selection strengths sa, sv > 1. The deviations are larger
in antibodies due to neglecting the linkage correlation between the variable and the conserved regions.
where θ˜a = θa(Nv/Na) and θ˜v = θv(Na/Nv). We denote the ensemble covariance of two stochastic variables x and y
by, 〈
x, y
〉 ≡ 〈(x− 〈x〉) (y − 〈y〉)〉 (S68)
and hence, 〈x, x〉 is the ensemble variance of the variable x. Similar forms of the stationary solutions apply to the
statistics of the binding affinity in the conserved interaction region, 〈MˆA,2〉, 〈Eˆ , MˆA,2〉, and can be found by setting
the viral mutation rate µv and the central moments MˆV,r equal to zero in equations (S59-S67). For brevity we do not
present the solutions of the central moments in the conserved region.
In equations (S47-S58), the evolution of each moment depends on the higher moments in the presence of selection,
which leads to an infinite moment hierarchy. However, in the regime where rescaled coefficients satisfy saθa < 1 and
svθv < 1, we can truncate the moment hierarchy. From the comparisons of the Wright-Fisher simulations with our
theoretical results we choose to truncate the hierarchy after the 4th moment. Furthermore, higher central moments
are fast stochastic variables (see e.g., [64] and the discussion in Section B.4 and Fig. S3), and their ensemble averages
can sufficiently characterize the evolution of the mean binding affinity E and the binding diversity MA,2, MˆA,2 and
MV,2. Therefore, we will only present ensemble-averaged equations for the 3
rd and 4th moments of the phenotype
distributions. In order to clarify the truncation of the moment hierarchy, we explicitly show the evolution equations
and their stationary solutions for the rescaled moments of the phenotype distribution, which are defined in eq. (S22).
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d
dτa
〈mA,3〉 = −6θa〈mA,3〉 − 8θa
( K3
E20K1
〈ε〉
)
− 6θ˜v 〈mA,3〉 − 3〈mA,3〉+ sa
[〈mA,4〉 − 3 〈(mA,2)2〉 ] (S69)
d
dτv
〈mV,3〉 = −6θv〈mV,3〉 − 8θv
( K3
E20K1
〈ε〉
)
− 6θ˜a 〈mV,3〉 − 3〈mV,3〉 − sv
[〈mV,4〉 − 3 〈(mV,2)2〉 ] (S70)
d
dτa
〈(mA,2)2〉 = −8θa
[〈(mA,2)2〉 − 〈mA,2〉]− 8θ˜v 〈(mA,2)2〉+ 〈mA,4〉 − 3 〈(mA,2)2〉 (S71)
d
dτv
〈(mV,2)2〉 = −8θv
[〈(mV,2)2〉 − 〈mV,2〉]− 8θ˜a 〈(mV,2)2〉+ 〈mV,4〉 − 3 〈(mV,2)2〉 (S72)
d
dτa
〈mA,4〉 = −8θa
[
〈mA,4〉 − 2 K4
`K22
− (3− 4/`) 〈mA,2〉
]
− 8θ˜v 〈mA,4〉+ 6
〈
(mA,2)
2
〉− 4〈mA,4〉 (S73)
d
dτv
〈mV,4〉 = −8θv
[
〈mV,4〉 − 2 K4
`K22
− (3− 4/`) 〈mV,2〉
]
− 8θ˜a 〈mV,4〉+ 6
〈
(mV,2)
2
〉− 4〈mV,4〉 (S74)
with θ˜a = θa(Nv/Na) and θ˜v = θv(Na/Nv). τa = t/Na and τv = t/Nv are the evolutionary times in natural units of
the neutral coalescence time in the antibody population Na and in the viral population Nv, respectively. The term
〈ε〉 = 2(saθa − svθv (Na/Nv))
/
(θa + θv (Na/Nv)) in equations (S69, S70) is the stationary solution for the rescaled
mean binding affinity up to orders of O(θ2a, θ2v). The stationary solutions for the rescaled central moments of the
antibody population follow,
〈
mA,2
〉
=
4θa
1 + 4(θa + θ˜v)
− 8θa
3 + 18(θa + θ˜v)
sa
[ K3
E20K1
〈ε〉 − 4saθ2a +O
(
θ3a
)]
+O(s2aθ2a) (S75)
〈
mA,3
〉
= −8
3
× θa
1 + 2(θa + θ˜v)
( K3
E20K1
〈ε〉
)
+
32
3
sa
[
θ2a +O(θ3a)
]
+O(s2aθ3a) (S76)
〈
(mA,2)
2
〉
=
8θa
3 + 28 (θa + θ˜v)
[1
`
K4
K22
+ 2θa(7− 4/`)
]
+O(saθ3a) (S77)
〈mA,4〉 = 24θa
3 + 28 (θa + θ˜v)
[1
`
K4
K22
+ 2θa(5− 4/`)
]
+O(saθ3a) (S78)
Similar solutions can be found for the central moments of binding affinity in the viral population mV,r, by replacing
the subscripts a and v in the equations above. The stationary solutions for the central moments of the binding
affinity in the conserved region of antibody population mˆA,r can be found by setting the viral mutation rate equal to
zero, θv = 0, and by using the characteristics of the conserved region i.e., genetic length ˆ` and sites contributions Kˆr
in equations (S75-S78). Fig. S1 shows a good agreement between the numerical results for the rescaled stationary
mean binding affinity 〈ε〉 = 〈E〉/E0, 〈εˆ〉 = 〈Eˆ〉/Eˆ0 from the Wright-Fisher simulations and the analytical solutions
(S59, S61), by using the stationary ensemble averages for the diversity of the binding affinity 〈mA,2〉, 〈mˆA,2〉 and
〈mV,2〉 in eq. (S75). Fig. S2 compares the analytical solution for the second central moments 〈mA,2〉 and 〈mV,2〉
with numerical results from the Wright-Fisher simulations, by inserting the empirical estimates of the higher
moments from the simulations as in equations (S63) and (S64), (dashed lines), and by using the analytical solutions
for the higher moments to estimate the stationary value for the phenotype diversity, as given by eq. (S75), (solid lines).
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FIG. S3: Time-dependent statistics. Auto-correlation of the stationary mean binding affinity in the variable region (red),
eq. (S81), has a shorter decay time than in the conserved region (yellow), eq. (S82). The decay time for the auto-correlation
of the mean phenotype in both variable and conserved regions, which is of order of the inverse mutation rate, is much longer
than the correlation time of the second moments (green, blue, purple), which decay on a timescale of N generations. Solid
lines are from stationary simulations, and dashed lines are the analytical results for the auto-covariance of the moments given
by, eq. (S81) (red), eq. (S82) (yellow) and eq. (S83) (black), normalized to have magnitude 1 at separation time ∆τ = 0.
Parameters are: all κi = κˆi = 1, ` = ˆ` = 50, Na = Nv = 1000, θa = θv = 1/50, sa = sv = sˆa = 1. Simulation results are
time-averaged over 104Na generations, with values sampled every Na generations, and first 100Na generations omitted.
B.4 Time-dependent statistics and separation of time-scales
Statistics of the mean phenotype. As we show below, the higher central moments MV,r and MA,r for (r > 1)
are fast stochastic variables. Therefore, it is sufficient to use their stationary ensemble averages to compute the finite
time correlation of the mean binding affinities, E(τ) and Eˆ(τ).
The time-dependent solution for the ensemble averaged mean affinity 〈E(τ)〉 and 〈Eˆ(τ)〉 at time τ , and the covariance
between two time-points τ2 ≥ τ1, starting from an initial condition at time τ0 = 0 with the ensemble averages for the
mean affinities 〈E(0)〉, 〈Eˆ(0)〉 and the diversities 〈E(0), E(0)〉, 〈Eˆ(0), Eˆ(0)〉 follows,
〈E(τ)〉 = (1− e−2(θa+θ˜v)τ ) 〈E〉+ e−2(θa+θ˜v)τ 〈E(0)〉 (S79)
〈Eˆ(τ)〉 = (1− e−2θaτ ) 〈Eˆ〉+ e−2θaτ 〈Eˆ(0)〉 (S80)
〈E(τ1), E(τ2)〉 = e−2(θa+θ˜v)τ2〈E(0), E(0)〉+
[ 〈MA,2〉
Na
+
〈MV,2〉
Nv
] ∫ τ1
0
e−2(θa+θ˜v)(τ1−τ
′)e−2(θa+θ˜v)(τ2−τ
′)dτ ′
= e−2(θa+θ˜v)τ2 〈E(0), E(0)〉+
[ 〈MA,2〉
4(θa + θ˜v)
+
〈MV,2〉
4(θ˜a + θv)
] [
e−2(θa+θ˜v)(τ2−τ1) − e−2(θa+θ˜v)(τ1+τ2)
]
(S81)
〈Eˆ(τ1), Eˆ(τ2)〉 = e−2θaτ2 〈Eˆ(0), Eˆ(0)〉+ 〈MˆA,2〉
4θa
[
e−2θa(τ2−τ1) − e−2θa(τ1+τ2)
]
(S82)
where 〈E〉 and 〈Eˆ〉 are the stationary values of the mean phenotype in the variable and the conserved interaction
regions, given by equations (S59, S61). Time τ is measured in units of the neutral coalescence time for antibodies,
Na. The characteristic time-scale for the decay of the mean binding affinity in the variable interaction region of the
virus is 1/(2(θa + θ˜v)) in units of Na, which is shorter than the time-scale for the conserved region, 1/2θa. Therefore,
binding affinity in the conserved region is correlated over a longer period of time compared to the variable region (i.e.,
about twice as long if θa ∼ θ˜v). The difference in time-scale explains the small covariance due to the genetic linkage
between the conserved and the variable region of the virus shown in Fig. S3.
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Statistics of the phenotype diversity. As shown in [64], the fluctuations in the phenotype diversity are scale
invariant, which is a consequence of coherent, genome-wide linkage-disequilibrium fluctuations in the absence of
recombination. It is generated by sampling from a set of genotypes with binding affinities Eα . in antibodies and
E. γ in viruses from the underlying distributions with variance MA,2 and MV,2, which scale like the genome length
`. These large fluctuations result in a relatively short correlation time for the phenotype diversity, shown in Fig. S3.
Similar to the mean binding affinity, we can estimate the typical lifetime of these fluctuations from the stationary
auto-correlation function,
〈MA,2(τa),MA,2(τ ′a)〉 ∼ e−(τa−τ
′
a), 〈MV,2(τv),MV,2(τ ′v)〉 ∼ e−(τv−τ
′
v) (S83)
where τa, τ
′
a are measured in units of the antibody neutral coalescence time Na, and τv, τ
′
v are measured in units of
the viral neutral coalescence time Nv. Fig. S3 shows the decay of the stationary auto-correlation for the diversity
of the binding affinity MA,2, MˆA,2 and MV,2 as a function of the evolutionary separation time ∆τ = τ − τ ′. It is
evident that the characteristic decay time for the phenotype diversity (S83) is much shorter than that of the mean
phenotype, given by the auto-correlation function in eqs. (S81, S82).
B.5 Alternative fitness models
Nonlinear activation probability based on average binding (nonlinear-averaged). We assume that the
growth rate (fitness) of an antibody is proportional to the logarithm of its activation probability given by eq. (S38),
which may be approximated by a linear function if the nonlinearity is small (S39). Here, we numerically study
the effect of nonlinear sigmoidal fitness functions by comparing the evolutionary dynamics of populations in fitness
landscapes with different values of nonlinearity β = β0
√
E20 + Eˆ
2
0 and binding threshold e
∗ = E∗/
√
E20 + Eˆ
2
0 , while
keeping the overall strength of (rescaled) selection, sa = caβ/(1 + exp[−βe∗]) constant. The strength of selection
corresponds to the slope of the approximate linear-averaged fitness function in eq. (S39).
As the rescaled nonlinearity β = β0E0 of the fitness function (S38) increases, the mean binding affinity E becomes
closer to the neutral value; see Fig. S4A. This is due to the sigmoid form of the fitness function, which reduces fitness
differences between genotypes at extreme values of binding affinity. Since mutations push the mean binding affinity
towards zero, the reduced advantage of binding at the extremes moves the stationary binding affinity towards zero.
Similar arguments suggest that the rate of adaptation in the antibody population should decrease as the fitness
landscapes become more non-linear. The rate of adaptation is determined by fitness flux [42, 43], and is approximately
equal to the variance of fitness in the population [39]; see Section C for detailed discussion. Due to the sigmoidal
shape of the fitness function, fitness differences become small at large values of binding affinity (i.e., the functional
antibodies), resulting in a reduction of the fitness variance in the population, and hence, a lower rate of adaptation.
However, this effect is less pronounced when the threshold for specific interaction is very large, e∗  1/β. In this case,
the fitness function is nearly linear for most antibodies, since their binding affinity fall below the binding threshold
e∗. In this regime, the fitness variance and the rate of adaptation are only sensitive to the selection strength sa (i.e.,
slope of fitness at e = 0), and not the nonlinearity of the fitness landscape. Evidently, the fitness variance (Fig. S4B)
is less sensitive to the non-linearity, than the mean binding affinity (Fig. S4A).
Nonlinear activation probability based on the strongest binding (nonlinear-EVD). We study a model for
activation of antibodies which is based on their strongest binding affinity with a subset of viruses. The basic assumption
is that an antibody attempts to bind to a set of viruses (which may be smaller than the viral population size), and
once a high affinity binding occurs, it begins to proliferate. Similar treatments have been introduced in the context
of T-cell activation [67, 68]. The probability distribution function, Π(E∗α .) of the strongest of R independent binding
interactions between the antibody Aα and the viral population {V} can be obtained using extreme value statistics.
According to extreme value theory, if the distribution of binding affinities for a given antibody has an exponential tail,
the corresponding distribution for its strongest binding affinity belongs to the class of Gumbel distributions [69]. In the
evolutionary regime that we study here, the amount of genetic polymorphism in the population of antibodies results
in a Gaussian-like distribution for the binding affinities, with mean Eα . + Eˆα ., and variance I
(2)
α . given by eq. (S11).
Therefore, the corresponding probability distribution for the strongest binding affinity out of R independent trials, is
a Gumbel distribution [69] with a peak at,
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FIG. S4: Alternative fitness models. (A) Stationary mean binding affinity and (B) rate of antibody adaptation (fitness
flux) due to selection, estimated by population fitness variance, for the nonlinear-averaged fitness model (black) and the
nonlinear-EVD fitness model with the number of interactions, R = 10 (red), R = 100 (green), and R = 1000 (blue). The mean
binding affinity is sensitive to the degree of non-linearity β, and binding threshold e∗, but it is not very sensitive to the number
of interactions R. The selection coefficient sa is defined as in eq. (S39). Dashed line in (B) indicates the expected fitness
variance for a linear-averaged fitness model, 〈φA〉 ' s2a〈mA,2〉, which is the selection component of the fitness flux in eq. (S91).
Parameters are: κi = κˆi = 1 for all sites, ` = 50, ˆ` = 0, Na = Nv = 1000, θa = θv = 1/50. Points are time averaged values
from simulations run for 105Na generations, with values sampled every Na generations, and data from first 100Na generations
discarded.
Eαmax = Eα . + Eˆα . +
√
2I
(2)
α . lnR (S84)
and a width Σα =
√
piI
(2)
α . /(12 lnR). If we assume that lnR  1, the distribution is sharply peaked, and Eαmax is
sufficient to describe it. In addition, we assume the activation probability is a sigmoid function of Eαmax,
p
A,max
(Aα) =
1
1 + exp[−β0(Eαmax − E∗)]
. (S85)
The fitness function fA,max(A
α; {V }) for the nonlinear-EVD model is related to the logarithm of the activation
probability,
fA,max(A
α; {V }) = ca log[pmax(Aα)] = −ca log(1 + exp[−β0(Eαmax − E∗)]) (S86)
where the coefficients are similarly defined as in eq. (S38). Fig. S4A shows the stationary mean binding affinity
for nonlinear-EVD fitness model. While the mean binding affinity is sensitive to the nonlinearity parameter β, it
is relatively insensitive to the number of interactions R, and behaves similarly to the nonlinear-averaged model.
This is not surprising given the logarithmic dependence of binding affinity on the number of interactions R in eq. (S84).
27
C. Fitness flux and coevolutionary transfer flux
The fitness flux φ(t) characterizes the adaptive response of a population by genotypic or phenotypic changes in
a population [42–44, 70, 71]. The cumulative fitness flux, Φ(τ) =
∫ t+τ
t
Nφ(t′)dt′, measures the total amount of
adaptation over an evolutionary period τ [43, 70]. The evolutionary statistics of this quantity is specified by the
fitness flux theorem [43]. In our model, the fitness flux for the antibodies φ
A
(t) and the viruses φ
V
(t) follow,
φ
A
(t) =
∑
α∈antibodies
∂F
A
(t)
∂xα
× dx
α(t)
dt
(S87)
φ
V
(t) =
∑
γ∈viruses
∂F
V
(t)
∂yγ
× dy
γ(t)
dt
(S88)
where, F
A
(t) and F
V
(t) are the mean fitness of the antibody and the viral populations at time t, and time is measured
in units of generations. It should be noted that the cumulative fitness flux for evolution in a constant environment
(equilibrium) is equal to the difference of the mean fitness between the final and the initial time points. However, the
cumulative fitness flux in time-dependent environments (non-equilibrium) depends on the whole evolutionary history
of the population, and captures its incremental adaptive response to the underlying environmental fluctuations.
We introduce a new measure of interaction between coevolving populations “transfer flux”, which is the change in
the mean fitness of a population due to the evolution of the opposing population. The transfer flux from antibodies
to viruses TA→V and from viruses to antibodies TV→A follow,
TA→V (t) =
∑
α∈antibodies
∂F
V
(t)
∂xα
× dx
α(t)
dt
(S89)
TV→A(t) =
∑
γ∈viruses
∂F
A
(t)
∂yγ
× dy
γ(t)
dt
(S90)
In the regime of substantial selection sa, sv & 1, the transfer flux in antagonistically interacting populations of
antibodies and viruses is always negative, implying that adaptation of one population reduces the fitness of the
opposing population.
The fitness flux and transfer flux are rates of adaptation and interaction that are time-independent only in the
stationary state. The total amount of adaptation for non-stationary evolution, where the fluxes change in time, can
be generally measured by the cumulative fitness and transfer flux. For coevolution in the linear-averaged fitness
landscape of equations (S39, S41) the cumulative fitness flux over an evolutionary period [t0 : t] for antibodies and
viruses follow from a simple genotype-to-phenotype projection,
〈ΦA(t0 : t)〉 =
〈
Na
∫ t
t′=t0
φ
A
(t′)dt′
〉
=
〈
Na
∫ t
t′=t0
dt′
(
∂F
A
(t′)
∂E(t′)
∂E(t′)
∂t′
∣∣∣
{V}
+
∂F
A
(t′)
∂Eˆ(t′)
∂Eˆ(t′)
∂t′
∣∣∣
{V}
)〉
=
〈∫ t/Na
t′=t0/Na
dt′
[−2θa (saε(t′) + sˆaεˆ(t′)) + (s2amA,2(t′) + sˆ2amˆA,2(t′))]
〉
(S91)
〈ΦV (t0 : t)〉 =
〈
Nv
∫ t
t′=t00
φ
V
(t′)dt′
〉
=
〈∫ t/Nv
t′=t0/Nv
dt′
[
2θvsvε(t
′) + s2vmV,2(t
′)
]〉
(S92)
The first terms (proportional to θ) in the integrants of eqs. (S91, S92) are the fitness changes due to mutations and
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the second terms are due to selection; the changes due to genetic drift are zero for the ensemble-averaged fitness flux
of the linear-averaged fitness landscapes in eqs. (S39, S41). In the regime of substantial selection sa, sv & 1, the
fitness flux in a polymorphic population asymptotically converges to the variance of the stationary fitness distribution
in the population (e.g., s2amA,2 + sˆ
2
a mˆA,2 for antibodies) [43], which is in accordance with the rate of adaptation
given by Fisher’s fundamental theorem and Price’s equation [39, 40].
Similarly, the cumulative transfer fluxes over an evolutionary period [t0 : t] read,
〈TA→V (t0 : t)〉 =
〈
Nv
∫ t
t′=t0
TA→V (t′)dt′
〉
=
〈
Nv
∫ t
t′=t0
(
∂F
V
(t′)
∂E(t′)
∂E(t′)
∂t′
∣∣∣
{V}
+
∂F
V
(t′)
∂Eˆ(t′)
∂Eˆ(t′)
∂t′
∣∣∣
{V}
)〉
= (Nv/Na)
〈∫ t/Nv
t′=t0/Nv
dt′
[
2θasv
(
ε(t′) + εˆ(t′)
)− sv (samA,2(t′) + sˆamˆA,2(t′))]〉 (S93)
〈TV→A(t0 : t)〉 =
〈
Na
∫ t
t′=t0
TV→A(t′)dt′
〉
= (Na/Nv)
〈∫ t/Na
t′=t0/Na
dt′ [−2θvsaε(t′)− sasvmV,2(t′)]
〉
(S94)
The first terms in equations (S93, S94) are the fitness changes due to mutation, the second terms are due to selection.
In the stationary state, the cumulative flux values grow linearly with the evolutionary time, and simplify to,
〈ΦA(τa)〉st. = −〈TV→A(τa)〉st. =
sa
θ˜a + θv
(sa〈mA,2〉θv + sv〈mV,2〉θa) τa (S95)
〈ΦV (τv)〉st. = −〈TA→V (τv)〉st. =
sv
θ˜v + θa
(sa〈mA,2〉θv + sv〈mV,2〉θa) τv (S96)
where we have substituted the expected values for the ensemble averaged binding affinities in the stationary state,
given by eqs. (S59, S61). τa = (t− t0)/Na and τv = (t− t0)/Nv are the evolutionary times respectively in natural units
of the neutral coalescence time in the antibody population Na and in the viral population Nv. In the stationary state,
the fitness flux in each population and the transfer flux from the opposing population sum up to 0, keeping the mean
fitness of both populations constant. Non-stationary states occur during transient evolutionary dynamics of the whole
population, or when considering a subset of the population, such as a clonal lineage, whose size fluctuates to fixation or
extinction. In particular, the imbalance between the fitness flux and the transfer flux may determine the evolutionary
fate of a clonal lineage, which we discuss in Section E. A convenient way to measure fitness and transfer flux is
from time-shifted fitness measurements, for the stationary (Fig. 4 and Fig. S5) and non-stationary (Fig. S6) conditions.
D. Signature of coevolution from time-shifted fitness measurements
Measuring interactions between antibody and viral populations sampled at different time points provides means to
quantify the amount of host-pathogen co-adaptation. We introduce the time-shifted binding affinity between viruses
at time t and antibodies at time t+ τ in the variable and in the conserved regions,
Eτ (t) =
∑
α,γ
Eαγx
α(t+ τ) yγ(t) (S97)
Eˆτ (t) =
∑
α,γ
Eˆαx
α(t+ τ)yγ(t) = Eˆ(t+ τ) (S98)
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FIG. S5: Stationary time-shifted binding affinity between antigens and antibodies. Analytical estimates (dashed
lines, eqs. (S102, S103)) for the ensemble-averaged time-shifted binding affinity 〈ετ 〉 between the viral population sampled at
time t, and the antibody population at time t + τ averaged over all t in the stationary state, show good agreements with
the numerical estimates of Wright-Fisher simulations (full lines), over a range of evolutionary parameters. Parameters are
Na = Nv = 1000 and κi = 1 for all sites, and the selection coefficients and the nucleotide diversity as indicated by the legend.
Results are time-averaged over 104Na generations, with first 100Na generations omitted.
and the corresponding rescaled quantities, ετ (t) = Eτ (t)/E0 and εˆτ (t) = Eˆτ (t)/Eˆ0. Since the virus cannot evolve
in the conserved region, the time-shifted binding affinity in this region Eˆτ (t) is identical to the non-shifted affinity
Eˆ(t+ τ) at time t+ τ . The time-shifted fitness for antibodies and viruses at time t in interaction with the opposing
population sampled at time t+ τ follow,
• time-shifted viral fitness:
NvFV ;τ (t) = −svετ (t) (S99)
• time-shifted antibody fitness:
NaFA;τ (t) = saε−τ (t+ τ) + sˆaεˆ(t) (S100)
As shown in Fig. 4, the behavior of the time-shifted binding affinity (or fitness) is primarily determined by the
strength of selection on the phenotype at short values of time-lag τ , and is characterized by randomizing mutations
at large separation times. Here, we analytically characterize the stationary state behavior of the time-shifted binding
affinity as a function of the separation time τ . The change in time-shifted binding affinity due to the affinity maturation
of antibodies (adaptation) to neutralize the focal viral population (i.e., for positive separation times τ > 0) follows,
d
dτ
〈ετ (t)〉 =
〈
1
E0
∑
α,γ
Eαγy
γ(t)
d
dτ
xα(t+ τ)
〉
= −2θ˜a〈ετ (t)〉+
〈
sa
E20
∑
α
Eα .(t) (Eα .(t+ τ)− E(t+ τ))xα(t+ τ)
〉
' −2θ˜a〈ετ (t)〉+ sa〈mA,2〉e−2θvτ (S101)
where time is measured in units of the viral coalescence time, Nv. We used a mean-field approach in the sta-
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FIG. S6: Non-stationary signature of coevolution from time-shifted fitness. Transient (non-stationary) coevolution
is quantified by the ensemble-averaged time-shifted mean fitness of the viral population sampled at a reference time point of
Nv generations after the beginning of the simulation, that is before the system reaches a stationary state; see eqs. (S81, S82).
For τ > 0, the time-shifted fitness 〈FV ;τ (0)〉 (S99) measures the fitness of the focal viral population at reference time 0 against
the antibodies sampled at time +τ . For τ < 0, we show 〈FV ;−τ (τ)〉, i.e., the time-shifted fitness with antibodies from t = 0
and viruses from time +τ . The fitness function is shown for two evolutionary regimes, (i) stronger viral selection, sv = 2,
sa = 1 (red) and (ii) weaker viral selection, sv = 1, sa = 2 (blue). The slope of time-shifted fitness at τ = 0 measures the
population’s fitness flux (dashed lines) and the transfer flux from the opposing population (dotted lines), estimated based on
the phenotype statistics measured in the simulations (S92, S93). Fitness flux and transfer flux do not have equal values in a
non-stationary state, leading to the discontinuity in the slope of the time-shifted fitness function at τ = 0. Parameters are
` = ˆ` = 50, Na = Nv = 1000, θa = θv = 1/50. Populations are evolved for Nv generations to reach the reference time τ = 0,
then data is collected over 100Nv generations. Results are ensemble-averaged over 10
3 initializations.
tionary state to approximate the finite-time divergence of the averaged binding affinity for a given antibody
in a time-varying environment of evolving viruses, i.e., 〈∑α xα(t+ τ)(Eα .(t+ τ)− E(t+ τ)) (Eα .(t)− E(t))〉 '
e−2θvτ
〈∑
α x
α(t+ τ)(Eα .(t+ τ)− E(t+ τ))2
〉
= e−2θvτ 〈MA,2〉. The behavior of the time-shifted binding affinity
at negative separation times τ < 0 is mainly determined by the adaptation (escape) of the viruses to the antibodies
in the past. In the stationary state, the backward dynamics of the time-shifted binding affinity with respect to the
focal viral population is equivalent to the forward dynamics with respect to the focal antibody population, which
can be evaluated similarly to eq. (S101). Combining the forward and the backward dynamics results in the following
functional form for the rescaled time-shifted binding affinity,
• for antibody affinity maturation, τ ≥ 0
〈ετ (t)〉 =

samA,2
2(θa−θ˜v) e
−2θvτ −
(
svmV,2
2(θ˜a+θv)
+
θvsamA,2
θaθ˜a−θv θ˜v
)
e−2θ˜aτ θa 6= θv
(
samA,2(Nv/Na)−svmV,2
4θ + samA,2(Nv/Na)τ
)
e−2θτ θ˜a = θv = θ
(S102)
• for viral escape, τ < 0
〈ετ (t)〉 =

svmV,2
2(θ˜a−θv) e
−2θ˜a|τ | +
(
samA,2
2(θa+θ˜v)
− θasvmV,2
θaθ˜a−θv θ˜v
)
e−2θv|τ | θa 6= θv
(
samA,2(Nv/Na)−svmV,2
4θ − svmV,2|τ |
)
e−2θ|τ | θ˜a = θv = θ
(S103)
with θ˜a = θa(Nv/Na) and θ˜v = θv(Na/Nv). Fig. 4 and Fig. S5 show good agreements between the numerical
results for the time-shifted fitness Nv〈FV ;τ 〉 = −sv〈ετ 〉 from the Wright-Fisher simulations and the analytical
solutions (S102, S103), in the stationary state. The slope of time-shifted fitness at time-lag τ = 0 is a measure of the
antibody population’s fitness flux (towards the past) and the transfer flux from the opposing population (towards
the future), which are equal in stationary state as depicted in Fig. 4 and Fig. S5. In the non-stationary state, the
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time-shifted fitness 〈FV ;τ (t)〉 may have a discontinuous derivative at τ = 0, due to an imbalance between fitness flux
and transfer flux (Fig. S6).
E. Evolution of multiple antibody lineages
Fixation probability in a general fitness landscape. We extend our results to multiple clonal antibody lineages
evolving with a viral population. We denote the frequency of an antibody lineage with size NCa by ρ
C = NCa /Na.
Assuming that mutations cannot change the identity of one lineage to another, the growth of a given lineage C depends
on the relative mean fitness of the lineage F
AC to the mean fitness of the whole population FA(t) =
∑
C FAC (t)ρC (t),
and on the strength of stochasticity due to genetic drift,
d
dt
ρC (t) =
∑
α
(
fCα (t)− FA(t)
)
xαC (t) +
√
ρC (1− ρC )
Na
(S104)
where fCα (t) is the fitness of the genotype A
α in the lineage C, and xαC ≡ xC(Aα) is the frequency of the genotype
Aα from lineage C in the total population. Similar to the evolution of a single lineage, the growth of multiple lineages
follows an infinite hierarchy of moment equations for the fitness distribution. Here, we truncate these equations at the
second central moment of fitness, which relates to the lineage-specific fitness flux φ
AC and the transfer flux TV→AC .
The changes of the ensemble-averaged mean fitness of a lineage F
AC (t) and the mean fitness of the whole population
F
A
(t), weighted by the lineage frequency ρC (t) follow,
〈
d
dt
∑
α
fCα (t)x
α
C (t)
〉
=
〈
ρC (t)
∑
α∈C
∂F
AC
∂xαC
× dx
α
C
dt
〉
+
〈
ρC (t)
∑
γ
∂F
AC
∂yγ
× dy
γ
dt
〉
− 1
Na
〈
F
AC (t) ρC (t)
〉
≡ 〈ρC (t)φAC (t)〉+ 〈ρC (t) TV→AC (t)〉− 1Na 〈FAC (t) ρC (t)〉 (S105)
〈
d
dt
∑
α
F
A
(t)xαC (t)
〉
=
〈
ρC (t)φA(t)
〉
+
〈
ρC (t) TV→A(t)
〉− 1
Na
〈
F
A
(t) ρC (t)
〉
(S106)
Here, we assume that the mean fitness of a lineage only depends on the genotypes within the lineage, as is the case
for the fitness functions given by eqs. (S39, S41). The ensemble-averaged changes of the fitness flux and the transfer
flux due to selection depend on higher central moments of the fitness distribution, which we neglect in our analysis.
The effects of mutation and genetic drift (using Itoˆ calculus) on the flux quantities follow,
d
dt
〈
ρC (t)φAC (t)
〉
'
〈
ρC (t)mAα
∂
∂xα
φ
AC (t)
〉
+
1
Na
[〈
ρC (t)φA(t)
〉− 2〈ρC (t)φAC (t)〉] (S107)
d
dt
〈
ρC (t)φA(t)
〉
'
〈
ρC (t)mAα
∂
∂xα
φ
A
(t)
〉
+
1
Na
[〈
ρC (t)φAC (t)
〉− 2〈ρC (t)φA(t)〉] (S108)
d
dt
〈
ρC (t) TV→AC (t)
〉
'
〈
ρC (t)
[
m
Aα
∂
∂xα
TV→AC (t) +mV γ
∂
∂yγ
TV→AC (t)
]〉
− 1
Nv
〈
ρC (t) TV→AC (t)
〉
(S109)
d
dt
〈
ρC (t) TV→A(t)
〉
'
〈
ρC (t)
[
m
Aα
∂
∂xα
TV→(t) +mV γ
∂
∂yγ
TV→A(t)
]〉
− 1
Nv
〈
ρC (t) TV→A(t)
〉
(S110)
where m
Aα
and m
V γ
are the mutational fields associated with the changes in genotype frequencies due to mutations
in antibodies and viruses, as defined by eq. (S1).
In order to compute the fixation probability Pfix = limt→∞〈ρC (t)〉, it is convenient to use the Laplace trans-
form of the lineage frequency, and compute its asymptotic behavior at large time (see e.g., [72]). The Laplace
transform of a given function A(t) can be computed as, A(z) = ∑tA(t) exp[−zt] with the inverse transform:
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A(t) = lim
T→∞
1
2pii
∫ γ+iT
γ−iT exp[zt]A(z). Following this procedure for the hierarchy of equations (S104-S110) entails a
general form for the fixation probability of a lineage, depending on the initial states of the antibody and the viral
populations,
Pfix(C) = lim
t→∞〈ρC (t)〉
=
〈
ρC (0)
〉
+
〈
Na
(
F
AC (0)− F (0)
)
ρC (0)
〉
+
1
3
〈
N2a
(
φ
AC (0)− φA(0)
)
ρC (0)
〉
−
〈
NaNv
(∣∣TV→AC (0)∣∣− ∣∣TV→A(0)∣∣) ρC (0)〉+O(θ〈(Nδf)2〉, 〈(Nδf)3〉) (S111)
where 〈(δf)r〉 denotes the rth central moment of the fitness distribution. Here, we have neglected the change in
fitness and transfer flux due to mutations, which is of the order of O(θ〈(Nδf)2〉). Below, we will explicitly study the
mutational terms for the specific case of the linear fitness model in eqs. (S39, S41). The first term in eq. (S111) is
the ensemble-averaged initial frequency of the lineage at time t = 0, and equals its fixation probability in neutrality.
In the presence of selection, lineages of antibodies with higher relative mean fitness, F
AC (0) − F (0), higher rate
of adaptation, φ
AC (0) − φA(0), and lower (absolute) transfer flux from viruses,
∣∣TV→AC (0)∣∣ − ∣∣TV→A(0)∣∣, tend to
dominate the population.
Fixation probability in the linear fitness landscape. In the linear-averaged fitness model (S39, S41), the growth
of a lineage depends on its relative binding affinity compared to the rest of the population. In order to quantify the
competition between the lineages, we define the following lineage-specific moments,
L
C
Am =
〈∑
α
(Eα . − E)m xαC
〉
, Lˆ
C
Am =
〈∑
α
(Eˆα . − Eˆ)m xαC
〉
(S112)
L
C
A(m;n)
=
〈∑
α
(Eα . − E)m xαC
∑
β,C′
(Eβ . − E)n xβC′
〉
(S113)
Lˆ
C
A(m;n)
=
〈∑
α
(Eˆα . − Eˆ)m xαC
∑
β,C′
(Eˆβ . − Eˆ)n xβC′
〉
(S114)
L
C
Am,Vk
=
〈∑
γ
(E. γ − E)kyγ
∑
α
(Eαγ − E)m xαC
〉
(S115)
In this notation the zeroth order lineage-specific moment is equal to the ensemble-averaged frequency of the focal
lineage L
C
A0
≡ 〈ρC 〉. As given by eq. (S107), the change in the frequency of the lineage C follows from the evolution
equation,
d
dt
L
C
A0 = Sa(L
C
A1 + Lˆ
C
A1) (S116)
The evolutionary dynamics of multiple lineages follows from an infinite hierarchy of moment equations. In order to
estimate the fixation probability of a lineage up to the order ofO((NS)2), it is sufficient to truncate the hierarchy at the
second moment. These hierarchy of evolution equations for the lineage-specific moments L
C
Am
and the cross-statistics
L
C
Am,Vk
follow,
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variable region:
d
dt
L
C
A1 = Sa
(
L
C
A2 − L
C
A(0;2)
)
− Sv
(
L
C
A1,V1 − L
C
A0,V2
)
− 2(µa + µv)LCA1 −
L
C
A1
Na
(S117)
d
dt
L
C
A2 = −4µa
(
L
C
A2 − `QC2
)
− 4µvLCA2 +
L
C
A(0;2)
− 2LCA2
Na
+O(Sa) (S118)
d
dt
L
C
A(0;2)
= −4µa
(
L
C
A(0;2)
− `QC(0;2)
)
− 4µvLCA(0;2) +
L
C
A2
− 2LCA(0;2)
Na
+O(Sa) (S119)
d
dt
L
C
A1,V1 = −4µaL
C
A1,V1 − 4µv
(
L
C
A1,V1 − `
√
QC2 Q
C
(0;2)
)
− L
C
A1,V1
Nv
+O(Sa, Sv) (S120)
d
dt
L
C
A0,V2 = −4µaL
C
A0,V2 − 4µv
(
L
C
A0,V2 − `QC(0;2)
)
− L
C
A0,V2
Nv
+O(Sa, Sv) (S121)
conserved region:
d
dt
Lˆ
C
A1 = Sa
(
Lˆ
C
A2 − Lˆ
C
A(0;2)
)
− 2µaLˆCA1 −
Lˆ
C
A1
Na
(S122)
d
dt
Lˆ
C
A2 = −4µa
(
Lˆ
C
A2 − ˆ`QˆC2
)
+
Lˆ
C
A(0;2)
− 2LˆCA2
Na
+O(Sa) (S123)
d
dt
Lˆ
C
A(0;2)
= −4µa
(
Lˆ
C
A(0;2)
− ˆ`QˆC(0;2)
)
+
Lˆ
C
A2
− 2LˆCA(0;2)
Na
+O(Sa) (S124)
with the lineage-specific statistics of the trait scale,
QC2 =
〈
ρC KC2
〉
, QC(0;2) =
〈
ρC
∑
lineages C′
KC′2 ρC′
〉
(S125)
QˆC2 =
〈
ρC KˆC2
〉
, QˆC(0;2) =
〈
ρC
∑
lineages C′
KˆC′2 ρC′
〉
(S126)
KC2 =
∑`
i=1(κ
C
i )
2
/
` and KˆC2 =
∑`+ˆ`
i=1+`(κˆ
C
i )
2
/
ˆ` are the averaged accessibilities for a given lineage C, similar to the
definition in eq. (S21). As indicated by eqs. (S117-S124), the composite lineage-specific trait statistics QC2 − QC(0;2)
and QˆC2 − QˆC(0;2) influence the evolution of the lineage frequency. These quantities vary over time due to changes in
the lineage composition of the population,
d
dt
(
QC2 −QC(0;2)
)
=
1
Na
(
QC2 −QC(0;2)
)
+O(Sa) (S127)
d
dt
(
QˆC2 − QˆC(0;2)
)
=
1
Na
(
QˆC2 − QˆC(0;2)
)
+O(Sa) (S128)
In order to compute the fixation probability, we use the Laplace transform of the lineage-specific moments
LCAm,Vk(z) and the lineage-specific statistics of the trait scale QC2 (z) − QC(0;2)(z), and compute the asymptotic
behavior of the 0th moment L
C
0 , after the inverse transform (see e.g., [66, 72]). The Laplace transform of the moment
hierarchy (S117-S124) up to order of O((NS)2) in LCA0 follows,
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zLCA0(z)− L
C
A,0(0) = Sa(L
C
A1(z) + Lˆ
C
1(z)) (S129)
variable region:
zLCA1(z)− L
C
A1(0) = Sa(L
C
A2(z)− L
C
A(0;2)
(z))− Sv(LCA1,V1 − L
C
A0,V2)− 2(µa + µv)L
C
A1(z)−
LCA1(z)
Na
(S130)
zLCA2(z)− L
C
A2(0) = −4µa
(
LCA2(z)− `QC2 (z)
)
− 4µvLCA2(z) +
LCA(0;2)(z)− 2L
C
A2
(z)
Na
(S131)
zLCA(0;2) − L
C
A(0;2)
(0) = −4µa
(
LCA(0;2) − `QC(0;2)(z)
)
− 4µvLCA(0;2) +
LCA2 − 2L
C
A(0;2)
Na
(S132)
zLCA1,V1 − L
C
A1,V1(0) = −4µaL
C
A1,V1 − 4µv
(
LCA1,V1 − `
√
QC2 (z)QC(0;2)(z)
)
− L
C
A1,V1
Nv
(S133)
zLCA0,V2 − L
C
A0,V2(0) = −4µaL
C
A0,V2 − 4µv
(
LCA0,V2 − `QC(0;2)(z)
)
− L
C
A0,V2
Nv
(S134)
z
(
QC2 (z)−QC(0;2)(z)
)
−
(
QC2 (0)−QC(0;2)(0)
)
=
1
Na
(
QC2 (z)−QC(0;2)(z)
)
(S135)
conserved region:
zLˆCA1(z)− Lˆ
C
A1(0) = Sa(Lˆ
C
A2(z)− Lˆ
C
A(0;2)
(z))− 2µaLˆCA1(z)−
LˆCA1(z)
Na
(S136)
zLˆCA2(z)− Lˆ
C
A2(0) = −4µa
(
LˆCA2(z)− ˆ`QˆC2 (z)
)
+
LˆCA(0;2)(z)− 2Lˆ
C
A2
(z)
Na
(S137)
zLˆCA(0;2) − Lˆ
C
A(0;2)
(0) = −4µa
(
LˆCA(0;2) − ˆ`QˆC(0;2)(z)
)
+
LˆCA2 − 2Lˆ
C
A(0;2)
Na
(S138)
z
(
QˆC2 (z)− QˆC(0;2)(z)
)
−
(
QˆC2 (0)− QˆC(0;2)(0)
)
=
1
Na
(
QˆC2 (z)− QˆC(0;2)(z)
)
(S139)
The inverse transform of LCA0(z) in the limit of z → 0 results in the asymptotic behavior of the ensemble-averaged
frequency of the lineage C, lim
t→∞L
C
A0
, which corresponds to the fixation probability P
fix
(C) of the lineage,
P
fix
(C) = lim
t→∞L
C
A0(t)
=L
C
A0(0) +
Na Sa
1 + 2(θa + θ˜v)
L
C
A1(0) +
Na Sa
1 + 2θa
Lˆ
C
A1(0)
+
(Na Sa)
2
(1 + 2(θa + θ˜v))
× 1
3 + 4(θa + θ˜v)
[
L
C
A2(0)− L
C
A(0;2)
(0) + 4θa`
(
Q2(0)−Q(0;2)(0)
)]
+
(Na Sa)
2
(1 + 2θa)
× 1
3 + 4θa
[
Lˆ
C
A2(0)− Lˆ
C
A(0;2)
(0) + 4θa ˆ`
(
Qˆ2(0)− Qˆ(0;2)(0)
)]
− (Nv Sv)(NaSa)
1 + 2(θa + θ˜v)
× 1
1 + 4(θa + θ˜v)
[
L
C
A1,V1(0)− L
C
A0,V2(0) + 4θv`
(√
Q(0;2)(0)Q2(0)−Q(0;2)(0)
)]
(S140)
The fixation probability of a lineage can be characterized by the state of the antibody and the viral population upon
its introduction. The first term in eq. (S140) is the frequency of the antibody lineage at the time of introduction, and is
equal to the neutral fixation probability. The terms proportional to the antibody selection coefficient (NaSa) measure
the relative fitness of the lineage C to the mean fitness of the population. The terms proportional to the (NaSa)2
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measure the relative fitness flux of the lineage C to the fitness flux of the whole population. The terms proportional
to (NaSa) × (NvSv) measure the transfer flux from the viral population to the antibody lineage C relative to the
total transfer flux from viruses to the antibody population. L
C
A(0;2)
and LA0,V2 = 〈ρCMV,2〉 are respectively the total
diversity of binding in the antibody and in the viral population, scaled by the frequency of the lineage C, and determine
the fitness flux and transfer flux associated with the whole antibody population. The diversity of binding affinity in
viruses is a population observable which affects the lineage fixation probability, as shown in Fig. 5.
The higher viral diversity favors the fixation of broadly neutralizing antibodies for two reasons. First, the larger
viral diversity compromises the mean fitness of the resident non-broad antibody population, and makes it easier for
the potential BnAb lineage to take over the existing antibody lineages. This effect is captured by terms proportional
to NaSa in eq. (S140). Second, the transfer flux from the viral population to the lineage with access to the conserved
interaction regions (i.e, a lineage with Eˆ20/E
2
0  1) is small. Therefore, the viral escape from binding to a potential
BnAb lineage is less efficient than from the resident non-broad antibody population, which increases the chance of
fixation for a potential BnAb lineage. This effect is captured by terms proportional to (NaSa)× (NvSv) in eq. (S140).
The approximation used to estimate the fixation probability in eq. (S140) is valid when the effective selection
pressure on the lineage (rescaled by the nucleotide diversity) is comparable to the effective pressure on viruses, i.e.,
(sCa −
∑
C′ s
C′
a ρC′ + sˆ
C
a −
∑
C′ sˆ
C′
a ρC′ )θa ∼ svθv, where sCa = NaSa(`KC2 )1/2 and sˆCa = NaSa(ˆ`KˆC2 )1/2 are the rescaled
selection coefficients of the focal lineage C in the variable and the conserved regions. Fig. 5 shows deviations between
analytical expectations from eq. (S140) and the outcome of the Wright-Fisher simulations beyond this approximation
regime. Specifically, the analytical predictions become less reliable for the case of an emerging BnAb lineage on
the background of a neutralizing resident population, which causes a strong selection imbalance between the two
populations. Including the higher order terms of the lineage-specific moments would improve the analytical predictions.
However, in the regime of very strong selection, the higher order terms of the series expansion in eq. (S140) become
very large (and of alternating sign), so that the fixation probability remains bounded (0 ≤ Pfix ≤ 1). In this regime,
we show that substituting the second order lineage-specific moments in eqs. (S117, S124) by their ensemble-averaged
expectation in neutrality,
LCA2 − LCA(0;2) ' 4θa`
(
Q
C
2(0)−Q
C
(0;2)(0)
)
, LˆCA2 − LˆCA(0;2) ' 4θa ˆ`
(
Qˆ
C
2(0)− Qˆ
C
(0;2)(0)
)
(S141)
could provide a more reliable approximation to the fixation probability as opposed to a higher order yet incomplete
expansion; see Fig. 5 (dashed lines).
F. Analysis of time-shifted neutralization data
The empirical study by Richman et al. [11] provides time-shifted measurements of viral neutralization by a patient’s
circulating antibodies, as the percent inhibition of viral replication at various levels of antibody dilution compared to
an antibody-negative control. The inhibition of the virus for a given concentration of antibodies in the serum [AB] is,
I =
[AB]
[AB] +K
(S142)
where K is a constant that equals the antibody concentration which inhibits 50% of viruses. The inhibition can be
written in terms of the plasma dilution dAB ,
I(V(t1),A(t2)) =
dAB(t2)
dAB(t2) + 1/titer(Vt1 , At2)
(S143)
where titer is the reciprocal of antibody dilution where inhibition reaches 50% (IC50). Inhibition by antibodies
reduces the replication rate of viruses from the maximum value in the absence of antibodies rmax by a factor 1 − I,
and results in population growth, Nv(t+1) = rmax(1−I)Nv(t), with a malthusian mean fitness for the viral population
Fv =
1
t−t0 log (Nv(t)/Nv(t0)) = log (rmax(1− I)). In the patient, the plasma is not diluted i.e., dAB ∼ 1. Therefore,
the viral fitness during infection can be approximately expressed in terms of the neutralization titer Fv ∼ − log(titer).
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FIG. S7: Neutralization titers of HIV against patients plasma. Neutralization activity (titer) of plasma against
autologous viruses collected at various time-points (colors) from two HIV patients, (A) TN-1 and (B) TN-3 as reported
by [11]. Neutralization titers are defined as the reciprocal of antibody dilution at the level that inhibition reaches 50% (IC50).
In addition, plasma activity against a neutralization-sensitive virus (NL43) is taken as a control measurement (dashed line),
which indicates an increasing antibody response over time.
A similar relation between neutralization titers and viral fitness has been previously suggested by Blanquart &
Gandon [45].
Additional control experiments show inhibition of a neutralization-sensitive virus (NL43) [11], which we denote by
I∗. In the stationary state, we expect that the titers (and fitness) associated with the neutralization-sensitive virus
to be comparable across serums of various time-points. However, due to a low antibody response at the initial stages
of the infection, the neutralization titers for both autologous viruses and the control NL43 virus grow as the infection
progresses; see Fig. S7. In order to account for this non-stationary antibody response, we evaluate the fitness as the
relative titers of the autologous viruses and the neutralization-sensitive virus (NL43) at each time-point. We define
the relative time-shifted mean fitness of the viral population at time t against the antibody serum sampled at time
t+ τ as,
FV ;τ (t) = c0 − log
(
titer(Vt, At+τ )
/
titer∗(At+τ )
)
(S144)
where titer∗(At+τ ) is the neutralization titer for NL43 virus against the serum sampled at time t + τ , and c0 is a
constant that relates the relative neutralization titers to the viral fitness. Fig. 4C shows the time-shifted relative mean
fitness FV ;τ (t) averaged over all time-points t, evaluated for two patients (TN-1 & TN-3) from the data provided by
Richman et al. [11]. Before averaging, we linearly interpolate the raw data to produce equal time shifts (3 months for
TN-1 and 6 months for TN-3). Due to the functional form of time-shifted fitness in eqs. (S102-S103), which involves
sums of two exponentials, brute force parameter scanning is necessary for a convergent solution. Our results indicate
comparable values of nucleotide diversity in antibodies and viruses θ˜a and θv. Therefore, we report fits to the simpler
analytical forms of time-shifted fitness with common θ’s given by eqs. (S102-S103), that use a single exponential
function to both sides of the data. Fits are found by scanning parameters and calculating the mean squared errors
with appropriate weights due to averaging over equal time-shifts. Each fit contains 4 composite variables which
are functions of the underlying evolutionary parameters: (i) nucleotide diversity θ, (ii) selection component of the
fitness flux in the viral population S2vMV,2, (iii) selection component of the transfer flux from antibodies to viruses,
−SaSvMA,2(Nv/Na), and (iv) the constant c0 in eq. (S144). Assuming that the derivative of the time-shifted fitness
function is continuous at the separation time τ = 0, the mean fitness of viruses interacting with their co-residing
antibody population can be evaluated dependent on the other fitted parameters, FV ;0 = (S
2
vMV,2 − SaSvMa,2)/4θ.
The fitted variables are listed below for both patients,
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diversity / month, sel. part of φV /month, sel. part of TA→V /month, offset,
θ · (month/Nv) S2vMV,2 −SaSvMA,2 c0
patient TN-1 0.07 0.69 −0.24 −0.24
patient TN-3 0.05 0.20 0 0.52
(S145)
The time-shifted fitness measurements match well with the analytical fits and indicate two distinct regimes of
coevolutionary dynamics in the two patients. In patient TN-1, viruses and antibodies experience a comparable
adaptive pressure, as indicated by the “S-curve” in Fig. 4C (blue line), with svmV,2/(samA,2) = 2.9. In patient
TN-3, adaptation in viruses is much stronger than in antibodies, resulting in an imbalanced shape of the time-shifted
fitness curve in Fig. 4C (red line). The lower overall neutralization titers in patient TN-3 (Fig. S7) is indicative of
such imbalance between the immune response and HIV escape in the patient. It is likely that a longer monitoring of
patient TN-3 would capture a stronger antibody response in later stages of infection.
Note that in these studies time is measured in units of months rather than coalescence time of the populations.
Estimating the coalescence time-scale in units of months would require analysis of genealogical relations between
sequences of antibodies and viruses extracted from each patient over the course of infection, which is not available
for this study.
G. Simulations
Simulations of the full genotype model (Wright-Fisher dynamics) were implemented as follows. Viral and antibody
populations consist of genotypes as strings of ±1 with length ` + ˆ`. Binding interactions are calculated between all
pairs of antibodies and viruses as in eq. (1), which define the fitness as in eqs. (2, 3). Genotypes within an antibody
lineage share the same accessibilities, {κi, κˆi}. For each generation, a poisson distributed number of mutations occur,
with each mutation flipping the sign of a site. Each generation is replaced by their offspring which inherit their parents’
genotype. Each parent generates a binomially distributed number of offspring, with probability proportional to the
exponential of its fitness, with the constraint that the total number of individuals remains constant Na in antibodies
and Nv in viruses, which is equivalent to multinomial sampling. Note that we define fitness as “malthusian”, which
means that fitness is the relative growth rate of genotypes, and the expected number of offspring is proportional to
the exponential of fitness.
Simulation parameters for all figures are Na = Nv = 10
3, ` = ˆ` = 50, θa = θv = 1/50, and all κi = κˆi = 1, unless
otherwise stated. Populations are initialized with all individuals having the same randomly generated genotype.
To measure quantities in the stationary state (Figs 2, 4) simulations are run for 104Na generations, and quantities
are averaged from samples every Na generations. Data from the beginning of the simulations are omitted from the
calculations, where the cutoff is τ = 2µ−1a , the correlation time for the mean binding (Fig. S3 and Section B.4 of the
Appendix). To produce the simulations shown in Fig. 5B, the newly emerging antibody lineages compete with the
resident population as follows. First, the resident lineage is evolved with the virus for 50Na generations to build up
diversity. Simultaneously, the invading lineage is evolved with the virus, except that the viral fitness is determined
only by the resident lineage. This ensures that invading lineages can marginally bind to the viral population, and
are functional lineage progenitors; a process that happens prior to affinity maturation in germinal centers. The pre-
adaptation of the invading lineage can also be interpreted as initial rounds of affinity maturation in germinal centers
isolated from competition with adapted antibody lineages. Then the two antibody lineages are combined with resident
at 90% and invader at 10%, with a total size of 103, and the state of the system is recorded. The two lineages are
evolved until one is extinct, repeated over 100 replicates to estimate the fixation probability. The whole procedure is
repeated 103 times for ensemble averaging. The invader, is either a normal lineage with all κi = 1 and κˆi = 0 or a
BnAb that binds only to the conserved region, κi = 0 and κˆi = 1.
Simulations are written in julia and code is available at https://github.com/jotwin/coevolution.
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